WO2020133361A1 - Kit for caring for the skin - Google Patents
Kit for caring for the skin Download PDFInfo
- Publication number
- WO2020133361A1 WO2020133361A1 PCT/CN2018/125363 CN2018125363W WO2020133361A1 WO 2020133361 A1 WO2020133361 A1 WO 2020133361A1 CN 2018125363 W CN2018125363 W CN 2018125363W WO 2020133361 A1 WO2020133361 A1 WO 2020133361A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- weight
- kit according
- polyvalent metal
- water soluble
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims abstract description 192
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 169
- 229920000642 polymer Polymers 0.000 claims abstract description 64
- 150000003839 salts Chemical class 0.000 claims abstract description 62
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 54
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 49
- 239000000463 material Substances 0.000 claims abstract description 41
- 229910052751 metal Inorganic materials 0.000 claims abstract description 41
- 239000002184 metal Substances 0.000 claims abstract description 41
- 239000002738 chelating agent Substances 0.000 claims abstract description 32
- 102000011782 Keratins Human genes 0.000 claims abstract description 17
- 108010076876 Keratins Proteins 0.000 claims abstract description 17
- 239000008346 aqueous phase Substances 0.000 claims abstract description 16
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 9
- 201000009859 Osteochondrosis Diseases 0.000 claims abstract description 7
- 206010072170 Skin wound Diseases 0.000 claims abstract description 7
- 208000031737 Tissue Adhesions Diseases 0.000 claims abstract description 7
- 238000011049 filling Methods 0.000 claims abstract description 7
- -1 alkali metal salts Chemical class 0.000 claims description 75
- 229920000615 alginic acid Polymers 0.000 claims description 60
- 239000000835 fiber Substances 0.000 claims description 60
- 235000010443 alginic acid Nutrition 0.000 claims description 57
- 239000000758 substrate Substances 0.000 claims description 54
- 229920002678 cellulose Polymers 0.000 claims description 41
- 229910052783 alkali metal Inorganic materials 0.000 claims description 40
- 235000010980 cellulose Nutrition 0.000 claims description 35
- 239000002253 acid Substances 0.000 claims description 29
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 29
- 150000001875 compounds Chemical class 0.000 claims description 24
- 150000001340 alkali metals Chemical class 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 22
- 239000003349 gelling agent Substances 0.000 claims description 18
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 17
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 17
- 229940072056 alginate Drugs 0.000 claims description 17
- 239000000783 alginic acid Substances 0.000 claims description 17
- 229960001126 alginic acid Drugs 0.000 claims description 17
- 150000004781 alginic acids Chemical class 0.000 claims description 16
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 16
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 16
- 229920001277 pectin Polymers 0.000 claims description 15
- 235000010987 pectin Nutrition 0.000 claims description 15
- 239000001814 pectin Substances 0.000 claims description 15
- 239000011734 sodium Substances 0.000 claims description 15
- 239000004745 nonwoven fabric Substances 0.000 claims description 14
- 229910052708 sodium Inorganic materials 0.000 claims description 14
- 229920001817 Agar Polymers 0.000 claims description 12
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 12
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 12
- 150000007513 acids Chemical class 0.000 claims description 12
- 239000011575 calcium Substances 0.000 claims description 12
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 12
- 229910052700 potassium Inorganic materials 0.000 claims description 12
- 235000010413 sodium alginate Nutrition 0.000 claims description 12
- 239000000661 sodium alginate Substances 0.000 claims description 12
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 11
- 239000013543 active substance Substances 0.000 claims description 11
- 229910052791 calcium Inorganic materials 0.000 claims description 11
- 229920001525 carrageenan Polymers 0.000 claims description 11
- 229940005550 sodium alginate Drugs 0.000 claims description 11
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 10
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 10
- 235000010419 agar Nutrition 0.000 claims description 10
- 239000011591 potassium Substances 0.000 claims description 10
- 239000001509 sodium citrate Substances 0.000 claims description 9
- 229920000742 Cotton Polymers 0.000 claims description 8
- 229920002148 Gellan gum Polymers 0.000 claims description 8
- 235000010410 calcium alginate Nutrition 0.000 claims description 8
- 239000000648 calcium alginate Substances 0.000 claims description 8
- 239000001175 calcium sulphate Substances 0.000 claims description 8
- 235000011132 calcium sulphate Nutrition 0.000 claims description 8
- 235000010418 carrageenan Nutrition 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- 229910052744 lithium Inorganic materials 0.000 claims description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 7
- 235000010492 gellan gum Nutrition 0.000 claims description 7
- 239000000216 gellan gum Substances 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- 150000001768 cations Chemical class 0.000 claims description 6
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 6
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 6
- 229920000297 Rayon Polymers 0.000 claims description 5
- 229960002681 calcium alginate Drugs 0.000 claims description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 5
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 5
- 238000013329 compounding Methods 0.000 claims description 5
- 229920013819 hydroxyethyl ethylcellulose Polymers 0.000 claims description 5
- 235000010408 potassium alginate Nutrition 0.000 claims description 5
- 239000000737 potassium alginate Substances 0.000 claims description 5
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims description 5
- VKZRWSNIWNFCIQ-WDSKDSINSA-N (2s)-2-[2-[[(1s)-1,2-dicarboxyethyl]amino]ethylamino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NCCN[C@H](C(O)=O)CC(O)=O VKZRWSNIWNFCIQ-WDSKDSINSA-N 0.000 claims description 4
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 4
- 229920000433 Lyocell Polymers 0.000 claims description 4
- 235000010216 calcium carbonate Nutrition 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 235000002949 phytic acid Nutrition 0.000 claims description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical class [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 claims description 3
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 claims description 3
- 239000010949 copper Chemical class 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 3
- 239000004627 regenerated cellulose Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- 229940083982 sodium phytate Drugs 0.000 claims description 3
- UZVUJVFQFNHRSY-OUTKXMMCSA-J tetrasodium;(2s)-2-[bis(carboxylatomethyl)amino]pentanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@@H](C([O-])=O)N(CC([O-])=O)CC([O-])=O UZVUJVFQFNHRSY-OUTKXMMCSA-J 0.000 claims description 3
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 claims description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims description 2
- DRAJWRKLRBNJRQ-UHFFFAOYSA-N Hydroxycarbamic acid Chemical class ONC(O)=O DRAJWRKLRBNJRQ-UHFFFAOYSA-N 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical class [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical class [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- 229910052712 strontium Inorganic materials 0.000 claims description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical class [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims description 2
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 claims description 2
- 239000011701 zinc Chemical class 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 claims 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 description 43
- 239000005017 polysaccharide Substances 0.000 description 43
- 150000004804 polysaccharides Chemical class 0.000 description 38
- 210000003491 skin Anatomy 0.000 description 36
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 28
- 239000000047 product Substances 0.000 description 28
- 229920002674 hyaluronan Polymers 0.000 description 27
- 229960003160 hyaluronic acid Drugs 0.000 description 26
- 244000303965 Cyamopsis psoralioides Species 0.000 description 25
- 210000001519 tissue Anatomy 0.000 description 22
- 239000001913 cellulose Substances 0.000 description 20
- 125000002091 cationic group Chemical group 0.000 description 19
- 229920000926 Galactomannan Polymers 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 14
- 125000004432 carbon atom Chemical group C* 0.000 description 13
- 239000000499 gel Substances 0.000 description 13
- 239000000839 emulsion Substances 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 11
- 229920002670 Fructan Polymers 0.000 description 11
- 125000000217 alkyl group Chemical group 0.000 description 11
- 229920001577 copolymer Polymers 0.000 description 11
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 10
- 125000000129 anionic group Chemical group 0.000 description 10
- 239000004744 fabric Substances 0.000 description 10
- 235000015424 sodium Nutrition 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 229920002307 Dextran Polymers 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 229920001202 Inulin Polymers 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 9
- 229920000728 polyester Polymers 0.000 description 9
- 229920001285 xanthan gum Polymers 0.000 description 9
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 description 8
- 229920003086 cellulose ether Polymers 0.000 description 8
- 230000032050 esterification Effects 0.000 description 8
- 238000005886 esterification reaction Methods 0.000 description 8
- 229920000591 gum Polymers 0.000 description 8
- 230000036571 hydration Effects 0.000 description 8
- 238000006703 hydration reaction Methods 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 230000009466 transformation Effects 0.000 description 8
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 7
- 240000008886 Ceratonia siliqua Species 0.000 description 7
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 7
- 229920002907 Guar gum Polymers 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 7
- 229920001218 Pullulan Polymers 0.000 description 7
- 239000004373 Pullulan Substances 0.000 description 7
- 229920002125 Sokalan® Polymers 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 7
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 7
- 229960002086 dextran Drugs 0.000 description 7
- 235000010417 guar gum Nutrition 0.000 description 7
- 239000000665 guar gum Substances 0.000 description 7
- 229960002154 guar gum Drugs 0.000 description 7
- 229920000609 methyl cellulose Polymers 0.000 description 7
- 235000010981 methylcellulose Nutrition 0.000 description 7
- 235000019423 pullulan Nutrition 0.000 description 7
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 6
- 229920002752 Konjac Polymers 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 229920002305 Schizophyllan Polymers 0.000 description 6
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 6
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 6
- 229940029339 inulin Drugs 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 229920000151 polyglycol Polymers 0.000 description 6
- 239000010695 polyglycol Substances 0.000 description 6
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical class [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 6
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 5
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 5
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 5
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 5
- 241000195493 Cryptophyta Species 0.000 description 5
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 229920002581 Glucomannan Polymers 0.000 description 5
- 229920000084 Gum arabic Polymers 0.000 description 5
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical group CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 5
- 235000010489 acacia gum Nutrition 0.000 description 5
- 239000000205 acacia gum Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 5
- 229940105329 carboxymethylcellulose Drugs 0.000 description 5
- 229960000633 dextran sulfate Drugs 0.000 description 5
- 239000000252 konjac Substances 0.000 description 5
- 235000010420 locust bean gum Nutrition 0.000 description 5
- 239000001923 methylcellulose Substances 0.000 description 5
- 229960002900 methylcellulose Drugs 0.000 description 5
- 235000011083 sodium citrates Nutrition 0.000 description 5
- 235000010491 tara gum Nutrition 0.000 description 5
- 239000000213 tara gum Substances 0.000 description 5
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 4
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 4
- 244000215068 Acacia senegal Species 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- 229920000161 Locust bean gum Polymers 0.000 description 4
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 4
- 241000206572 Rhodophyta Species 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000000061 acid fraction Substances 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 4
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
- 229920001249 ethyl cellulose Polymers 0.000 description 4
- 238000012854 evaluation process Methods 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 229930182830 galactose Natural products 0.000 description 4
- 229960003082 galactose Drugs 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 235000019823 konjac gum Nutrition 0.000 description 4
- 239000000711 locust bean gum Substances 0.000 description 4
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 241000416162 Astragalus gummifer Species 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000206672 Gelidium Species 0.000 description 3
- 229920001503 Glucan Polymers 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 241000282372 Panthera onca Species 0.000 description 3
- 241000199919 Phaeophyceae Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 229920001615 Tragacanth Polymers 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 3
- 125000002877 alkyl aryl group Chemical group 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 229920000617 arabinoxylan Polymers 0.000 description 3
- 150000004783 arabinoxylans Chemical class 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
- 150000002016 disaccharides Chemical group 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 235000019325 ethyl cellulose Nutrition 0.000 description 3
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 3
- 229940097043 glucuronic acid Drugs 0.000 description 3
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229950006780 n-acetylglucosamine Drugs 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 229920005646 polycarboxylate Polymers 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 229940068968 polysorbate 80 Drugs 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 235000019263 trisodium citrate Nutrition 0.000 description 3
- 229940038773 trisodium citrate Drugs 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- 229920001221 xylan Polymers 0.000 description 3
- 150000004823 xylans Chemical class 0.000 description 3
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 3
- VCVKIIDXVWEWSZ-YFKPBYRVSA-N (2s)-2-[bis(carboxymethyl)amino]pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)N(CC(O)=O)CC(O)=O VCVKIIDXVWEWSZ-YFKPBYRVSA-N 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-SYJWYVCOSA-N (2s,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-SYJWYVCOSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 2
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 2
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 2
- GHPVDCPCKSNJDR-UHFFFAOYSA-N 2-hydroxydecanoic acid Chemical compound CCCCCCCCC(O)C(O)=O GHPVDCPCKSNJDR-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 244000247812 Amorphophallus rivieri Species 0.000 description 2
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 2
- 229920000945 Amylopectin Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229920003043 Cellulose fiber Polymers 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 244000298479 Cichorium intybus Species 0.000 description 2
- 235000007542 Cichorium intybus Nutrition 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 235000017367 Guainella Nutrition 0.000 description 2
- 229920000869 Homopolysaccharide Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 2
- 241001598113 Laminaria digitata Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229920000057 Mannan Polymers 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229920013820 alkyl cellulose Polymers 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- AEMOLEFTQBMNLQ-ORELYVPDSA-N alpha-L-glucopyranuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O AEMOLEFTQBMNLQ-ORELYVPDSA-N 0.000 description 2
- 230000009435 amidation Effects 0.000 description 2
- 238000007112 amidation reaction Methods 0.000 description 2
- 238000005576 amination reaction Methods 0.000 description 2
- 229940035674 anesthetics Drugs 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 150000001277 beta hydroxy acids Chemical class 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000006266 etherification reaction Methods 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003193 general anesthetic agent Substances 0.000 description 2
- 229940046240 glucomannan Drugs 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 2
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940031674 laureth-7 Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- UBXAKNTVXQMEAG-UHFFFAOYSA-L strontium sulfate Chemical compound [Sr+2].[O-]S([O-])(=O)=O UBXAKNTVXQMEAG-UHFFFAOYSA-L 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 125000005208 trialkylammonium group Chemical group 0.000 description 2
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- WZYRMLAWNVOIEX-MOJAZDJTSA-N (2s)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyacetaldehyde Chemical group O=C[C@@H](O)[C@@H]1OC[C@H](O)[C@H]1O WZYRMLAWNVOIEX-MOJAZDJTSA-N 0.000 description 1
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 1
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- AACHVWXCVWWMSI-UHFFFAOYSA-N 3-hydroxypropyl(trimethyl)azanium Chemical group C[N+](C)(C)CCCO AACHVWXCVWWMSI-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- BDDLHHRCDSJVKV-UHFFFAOYSA-N 7028-40-2 Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O BDDLHHRCDSJVKV-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000199897 Alaria esculenta Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 239000001884 Cassia gum Substances 0.000 description 1
- 229920008347 Cellulose acetate propionate Polymers 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 125000003436 D-mannopyranosyl group Chemical group [H]OC([H])([H])[C@@]1([H])OC([H])(*)[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H] 0.000 description 1
- 125000000214 D-xylosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)CO1)* 0.000 description 1
- 244000115658 Dahlia pinnata Species 0.000 description 1
- 235000012040 Dahlia pinnata Nutrition 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000004455 Fucus spiralis Species 0.000 description 1
- 241000227647 Fucus vesiculosus Species 0.000 description 1
- 241001134786 Furcellaria Species 0.000 description 1
- 241001134784 Furcellariaceae Species 0.000 description 1
- 229920001706 Glucuronoxylan Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 241001428260 Hypneaceae Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- NGEWQZIDQIYUNV-UHFFFAOYSA-N L-valinic acid Natural products CC(C)C(O)C(O)=O NGEWQZIDQIYUNV-UHFFFAOYSA-N 0.000 description 1
- 241001466453 Laminaria Species 0.000 description 1
- 241000296380 Laminaria hyperborea Species 0.000 description 1
- 241001260563 Lessonia nigrescens Species 0.000 description 1
- 241000439036 Lessonia trabeculata Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 241001491705 Macrocystis pyrifera Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 229920003091 Methocel™ Polymers 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241001428125 Polyideaceae Species 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UHFFFAOYSA-N Rohrzucker Natural products OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 description 1
- 241000015177 Saccharina japonica Species 0.000 description 1
- 241000983746 Saccharina latissima Species 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical class C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 229920001284 acidic polysaccharide Polymers 0.000 description 1
- 150000004805 acidic polysaccharides Chemical class 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical group C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 125000003550 alpha-D-galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-N alpha-L-IdopA-(1->3)-beta-D-GalpNAc4S Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS(O)(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C(O)=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-N 0.000 description 1
- HMFHBZSHGGEWLO-QMKXCQHVSA-N alpha-L-arabinofuranose Chemical group OC[C@@H]1O[C@@H](O)[C@H](O)[C@H]1O HMFHBZSHGGEWLO-QMKXCQHVSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000019824 amidated pectin Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229920006321 anionic cellulose Polymers 0.000 description 1
- 229920001586 anionic polysaccharide Polymers 0.000 description 1
- 150000004836 anionic polysaccharides Chemical class 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002682 anti-psoriatic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 150000005840 aryl radicals Chemical class 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 125000000188 beta-D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N beta-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 description 1
- WQZGKKKJIJFFOK-RWOPYEJCSA-N beta-D-mannose Chemical group OC[C@H]1O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-RWOPYEJCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000019318 cassia gum Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 150000001773 cellobioses Chemical class 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229940107200 chondroitin sulfates Drugs 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229940119744 dextran 40 Drugs 0.000 description 1
- 229940119743 dextran 70 Drugs 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 239000002526 disodium citrate Substances 0.000 description 1
- 235000019262 disodium citrate Nutrition 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003089 ethylhydroxy ethyl cellulose Polymers 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 150000002232 fructoses Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000451 gelidium spp. gum Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- CBKLICUQYUTWQL-XWGBWKJCSA-N methyl (3s,4r)-3-methyl-1-(2-phenylethyl)-4-(n-propanoylanilino)piperidine-4-carboxylate;oxalic acid Chemical compound OC(=O)C(O)=O.CCC(=O)N([C@]1([C@H](CN(CCC=2C=CC=CC=2)CC1)C)C(=O)OC)C1=CC=CC=C1 CBKLICUQYUTWQL-XWGBWKJCSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical group COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 description 1
- 239000002524 monosodium citrate Substances 0.000 description 1
- 235000018342 monosodium citrate Nutrition 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WZZVUHWLNMNWLW-UHFFFAOYSA-N n-[5-[3-acetamido-5-[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound OC1C(NC(=O)C)C(O)OC(CO)C1OC1C(NC(C)=O)C(O)C(OC2C(C(O)C(O)C(CO)O2)NC(C)=O)C(CO)O1 WZZVUHWLNMNWLW-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- XNQULTQRGBXLIA-UHFFFAOYSA-O phosphonic anhydride Chemical compound O[P+](O)=O XNQULTQRGBXLIA-UHFFFAOYSA-O 0.000 description 1
- 229960004838 phosphoric acid Drugs 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 239000004854 plant resin Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical class [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- AVTYONGGKAJVTE-UHFFFAOYSA-L potassium tartrate Chemical class [K+].[K+].[O-]C(=O)C(O)C(O)C([O-])=O AVTYONGGKAJVTE-UHFFFAOYSA-L 0.000 description 1
- 239000001472 potassium tartrate Substances 0.000 description 1
- 235000011005 potassium tartrates Nutrition 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 150000004717 pyruvic acids Chemical class 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- HELHAJAZNSDZJO-UHFFFAOYSA-L sodium tartrate Chemical class [Na+].[Na+].[O-]C(=O)C(O)C(O)C([O-])=O HELHAJAZNSDZJO-UHFFFAOYSA-L 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- RVEZZJVBDQCTEF-UHFFFAOYSA-N sulfenic acid Chemical compound SO RVEZZJVBDQCTEF-UHFFFAOYSA-N 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical group 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/882—Mixing prior to application
Definitions
- the present invention relates to an alginic system, especially to an alginic kit caring for the skin. Further, the present invention relates to use of same, especially as a mask for caring for keratin materials, especially the skin.
- compositions for caring for keratin materials in particular the skin
- masks are known to have high penetration efficacy on the keratin materials.
- a two-digit market growth of mask cosmetic products in China was seen.
- paste type and peel-off type masks are mainly used for cleansing of the keratin materials, whereas gel type and wet tissue type masks are more often used for caring for the skin.
- gel type masks having good adhesion to the skin and can provide good fresh feel, however, may be insufficient in delivering moisturizing or hydration effect to the skin, while a wet issue type mask is good at delivering moisturizing and hydration effect, but will take it back if applied for an elongated period of time.
- the adhesion with the skin may not be as good as the gel type masks.
- the mask to be applied on face is soft, bringing better touch feeling and better fitness to the skin.
- masks which is capable of texture transformation, for example, from tissue to gel, creating a pleasant consumer experience.
- masks which have a moisture or actives delivery capacity that is at least on par with or even greater than that observed with wet tissue type masks.
- masks which can deliver moisturizing effect or actives to keratin materials for an elongated period of time and does not take it back, whereby exhibiting further improved e.g. hydration effect as compared with wet tissue type masks.
- the present inventors discovered that the conception or gist of the present invention is applicable not only to the cosmetic field, but also to other fields like the medical field, then the masks of the preceding aspects may be broadened to kits, which show the benefits described herein in connection with these masks as well.
- the present inventors have discovered that a specific combination of 1) a first composition comprising at least one water insoluble salt of polyvalent metal, as an ion donator of the polyvalent metal, and at least one water soluble polyhydroxy polymer; and 2) a second composition comprising at least one aqueous phase, and a) optionally, at least one water soluble chelating agent of the polyvalent metal ion, and b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion may satisfy one or more of the abovementioned requirements.
- One subject of the invention is thus to provide a kit comprising the first composition and the second composition separately placed from one another.
- a mask package 1 comprising: 1) a first composition comprising at least one water insoluble salt of polyvalent metal, at least one fiber rich in hydroxy groups, and at least one water soluble polyhydroxy polymer, and 2) a fourth composition comprising at least one aqueous phase, and, b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion; wherein the first composition and the fourth composition are separately placed from one another.
- Another subject of the present invention is use of the second composition as juice or a part of juice for mask product, wherein the mask product comprises, separate from the second composition, a fabric (or tissue) comprising at least one water insoluble salt of polyvalent metal according to the invention.
- kits according to the present invention for caring for keratin materials, especially the skin.
- This use may manifest itself as a process for caring for keratin materials, especially the skin, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to said keratin materials the thus obtained mixture.
- kits according to the present invention for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, and so on.
- This use may manifest itself as a process for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to a location in need of the thus obtained mixture.
- the “keratin material” is the skin.
- skin we intend all the body skin.
- the keratin material is the face, or the neck, especially the face.
- topical application it meant that the composition is applied or spread onto the surface of the keratin materials, such as at least one zone of the skin.
- rinse off it is meant a composition which after being applied on the skin for a predetermined period of time, is removed from the skin by a rinsing composition such as water.
- alkali metal refers to an element located in Group IA of the periodic table, such as sodium, potassium, lithium or a combination thereof, preferably sodium, potassium or a combination thereof.
- water-soluble or water-dispersible means a compound which, when introduced into water at 25°C, at a mass concentration equal to 1%, make it possible to obtain a macroscopically homogeneous and transparent solution, i.e. a solution with a maximum light transmittance value, at a wavelength equal to 500 nm, through a sample 1 cm thick, of at least 60%and preferably of at least 70%.
- the kit comprises a first composition and a second composition.
- the first composition according to the present invention comprises at least one water insoluble salt of polyvalent metal and at least one water soluble polyhydroxy polymer.
- water insoluble means that the salt is not dissolvable, e.g., having a solubility of less than 0.01g/100g of water or only slightly soluble, e.g., having a solubility of less than 0.5g/100g of water, in water, nor does it break apart in the bulk state upon immersion in water.
- the at least one water insoluble salt of polyvalent metal may be present in form of powder, particulate, fiber or bulk state.
- the term "particulate" when being used for the water insoluble salt of polyvalent metal, means that the salt is in the form of particles.
- water insoluble salt of polyvalent metal may be formed from an acid anion and a polyvalent metal cation, especially calcium, strontium, zinc, copper, manganese, aluminum, or mixtures thereof.
- the useful metal is preferably calcium, copper or a mixture thereof, more preferably calcium.
- the acid to provide acid anion according to the present invention can be any known acid useful in cosmetic products, provided that the salt formed from the acid with the polyvalent metal is water insoluble or slightly soluble.
- the typical acids may be used comprise various inorganic acids, e.g., sulphate, carbonic acid, phosphoric acid meta-aluminic acid, silicic acid, and various organic acids, especially higher saturated or unsaturated fatty acids, in particular those having 18 or more carbon atoms, e.g., stearic acid and oleic acid, or polycarboxylic acids, especially e.g., alginic acid, oxalic acid, as long as the salt formed is water insoluble or slightly soluble.
- the at least one water insoluble salt of polyvalent metal may be a sulphate or alginate, preferably chosen from calcium sulphate/alginate, strontium sulphate/alginate, zinc sulphate/alginate, copper sulphate/alginate, manganese sulphate/alginate, or a mixture thereof, preferably calcium sulphate/alginate or copper sulphate/alginate, in particular calcium sulphate/alginate.
- alginate in particular means a salt of alginic acid.
- Alginic acid a natural substance obtained from brown algae or from certain bacteria, is a polyuronic acid composed of two uronic acids linked together via 1, 4-glycoside bonds: ⁇ -D-mannuronic acid (M) and ⁇ -L-glucuronic acid (G) .
- Water insoluble alginates in which the principal cation is calcium, are specifically found in the fronds and stems of seaweeds of the class Phaeophyceae, examples of which are Fucus vesiculosus, Fucus spiralis, Ascophyllum nodosum, Macrocystis pyrifera, Alaria esculenta, Eclonia maxima, Lessonia nigrescens, Lessonia trabeculata, Laminaria japonica, Durvillea antarctica, Laminaria hyperborea, Laminaria longicruris, Laminaria digitata, Laminaria saccharina, Laminaria cloustoni, and Saragassum sp.
- Suitable water insoluble alginates have a weight-average molecular weight of about 20,000 Daltons to about 500,000 Daltons.
- the weight-average molecular weight is calculated by first determining the intrinsic viscosity, then using the Mark-Houwink Sakurada Equation, as in Martinsen, et al, "Comparison of Different Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates” (Carbohydr. Polym., 15, 171-193, 1991) .
- polyhydroxy polymer means a hydroxy-containing nonionic polysaccharide.
- fiber rich in hydroxy groups means a fiber having at least 2 hydroxy groups, preferably at least 3 hydroxy groups, per repeating unit of the polymer of the fiber and having at least one hydroxy-containing side chain, wherein less than 60%, preferably less than 30%, or preferably less than 15%, of hydroxy groups in the side chains are substituted.
- Useful water soluble polyhydroxy polymers comprise polyhydroxycarboxylic acids, esters of the acids; polyhydroxy celluloses; and the like.
- Some celluloses are known to be useful for promoting gelling behavior. Accordingly, polyhydroxy celluloses are preferably useful.
- nonionic polyhydroxy cellulose ethers are specially preferable, in which mention may be made of hydroxyalkylcelluloses such as hydroxymethylcelluloses, hydroxyethylcelluloses (HEC) and hydroxypropylcelluloses (HPC) ; and mixed hydroxyalkylalkylcelluloses such as hydroxy propylmethylcelluloses, hydroxy ethylmethylcelluloses, hydroxy ethylethylcelluloses and hydroxybutylmethylcelluloses.
- hydroxyalkylcelluloses such as hydroxymethylcelluloses, hydroxyethylcelluloses (HEC) and hydroxypropylcelluloses (HPC)
- HEC hydroxypropylcelluloses
- mixed hydroxyalkylalkylcelluloses such as hydroxy propylmethylcelluloses, hydroxy ethylmethylcelluloses, hydroxy ethylethylcelluloses and hydroxybutylmethylcelluloses.
- the first composition of the present invention may comprise the at least one water soluble polyhydroxy polymer in a content ranging from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, relative to the total weight of the first composition.
- the first composition may comprise at least one superabsorbent material.
- the at least one superabsorbent material may be present in form of powder, particulate, fiber or bulk state.
- the superabsorbent material advantageously presents very great ability to absorb a liquid, and in particular water. In particular, it may present the capacity to absorb 15 times, or even 20 times to 50 times its own weight in water, e.g. about 25 times to 30 times.
- the capacity of the superabsorbent material for absorbing liquid can be determined by implementing the following method.
- M D dry state
- the superabs orbent material is obtained in the "dry" state by being treated in a drying oven for about 4 hours (h) at about 50°C.
- Water (or any other liquid that is to be absorbed by the material) is put into contact with the material. This can be done either by immersing the material in the liquid, or else by pouring the liquid onto the material. For example, the material may be immersed for a duration of about 1 minute (min) .
- the quantity of water (or liquid) is used in excess so as to saturate the material completely, for example.
- the excess water (or liquid) is then eliminated, e.g. by drip-drying for about 2 min, and the material saturated in liquid is weighed (M L ) .
- the difference ⁇ between the weight of the material when saturated in liquid and the weight of the material when dry represents the quantity of liquid that it has absorbed, which weight is compared with the dry weight of the material.
- the resulting value C is indicative of the capacity of the superabsorbent material to absorb the liquid, e.g. expressed in grams of liquid absorbed per gram of dry material:
- the superabsorbent material may be selected from cellulose derivatives, alginates (not including the water insoluble alginates and the alkali metal alginic compounds described herein as the water soluble gelatinizing agent) and derivatives thereof, in particular derivatives such as propylene glycol alginate, or salts thereof, derivatives of polyacrylic acid or polymethacrylic acid, derivatives of poly (meth) acrylamide, derivatives of polyvinylpyrrolidone, derivatives of poly-vinyl ether, and mixtures thereof, amongst others.
- alginates not including the water insoluble alginates and the alkali metal alginic compounds described herein as the water soluble gelatinizing agent
- derivatives thereof in particular derivatives such as propylene glycol alginate, or salts thereof, derivatives of polyacrylic acid or polymethacrylic acid, derivatives of poly (meth) acrylamide, derivatives of polyvinylpyrrolidone, derivatives of poly-vinyl ether, and mixture
- the superabsorbent material may be selected from derivatives of chemically modified cellulose.
- it may be selected from carboxy-methyl cellulose, sodium carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, carboxyethyl cellulose, hydroxyethylethyl cellulose, hydroxypropylmethyl cellulose, methyl cellulose, sodium methyl cellulose, microcrystalline cellulose, sodium cellulose sulfate, and mixtures thereof.
- alkyl celluloses may also be selected from alkyl celluloses. These polymers are obtained by grafting an alkyl residue onto one or more hydroxy groups of the cellulose polymer to form the hydroxyalkyl derivative. These alkyl residues may be selected from the following groups: stearyl, isostearyl, lauryl, myristyl, cetyl, isocetyl, cocoyl, palmityl, oleyl, linonyl, ricinolyl, behenyl, and mixtures thereof. These hydroxyalkyl cellulose derivatives may also be subjected to chemical modification, e.g. using a carboxylic residue.
- the superabsorbent material may also be selected from natural polymer derivatives, such as, for example, gellan gum and glucomannan and galactomannan polysaccharides extracted from seeds, vegetable fibers, fruit, seaweed, starch, plant resins, or indeed of microbial origin.
- natural polymer derivatives such as, for example, gellan gum and glucomannan and galactomannan polysaccharides extracted from seeds, vegetable fibers, fruit, seaweed, starch, plant resins, or indeed of microbial origin.
- it may be selected from agar gum, guar gum, gum tragacanth, carrageenan gum, konjac gum, locust bean gum, gellan gum, xanthan gum, and mixtures thereof.
- the first composition of the present invention may comprise the at least one superabsorbent material in a content ranging from 0%to 80%by weight, especially from 50%to 80%by weight, or even the rest, relative to the total weight of the first composition.
- the first composition further comprises additional fibers other than one formed from the at least one water insoluble salt of polyvalent metal, where the at least one water insoluble salt of polyvalent metal and the at least one water soluble polyhydroxy polymer are loaded to the additional fibers.
- the water insoluble salt of polyvalent metal may be present in form of fiber. Then, the fiber of the at least one water insoluble salt of polyvalent metal may, solely or together with one or more other fibers, be formed into a water insoluble substrate. The water soluble polyhydroxy polymer is loaded to the substrate.
- the water insoluble salt of polyvalent metal, as well as the water soluble polyhydroxy polymer may be each distributed uniformly in a water insoluble substrate.
- water insoluble means that the substrate is not dissolvable in water, nor does it break apart upon immersion in water.
- Embodiment 1 is a diagrammatic representation of Embodiment 1:
- the substrate may be a woven or nonwoven fabric made of a fiber of the at least one water insoluble salt of polyvalent metal (also referred to as water insoluble polyvalent metal salt fiber hereinafter) together with at least one other fiber chosen from natural fibers such as cotton, pulp, bamboo and cellulose fibers, semi-natural fibers such as viscose rayon fibers, synthetic fibers such as polyester fibers, polyethylene terephthalate fibers, polyethylene fibers and polypropylene fibers. Two or more selected from the other fibers may be used in combination.
- polyvalent metal also referred to as water insoluble polyvalent metal salt fiber hereinafter
- fibers rich in hydroxy groups can be readily softened with a water soluble polyhydroxy polymer. Accordingly, fibers rich in hydroxy groups are preferably used according to the present invention. Such fibers can be regenerated cellulose or cotton fiber. Examples of fibers rich in hydroxy groups comprise Viscose, Modal, Lyocell, Cupro, Cotton and the like.
- the substrate can be made into a wide variety of shapes and forms such as flat pads, thick pads, thin sheets of irregular thickness, depending on the desired use and characteristic of the kit.
- the substrate is typically designed to fit the area of the skin in the case of mask to which topical application is desired.
- the substrate is designed to correspond to the shape of the face avoiding the eye, nostril, and mouth areas, as necessary.
- Non-limiting examples of the substrates useful in the present invention are described, for example, in the patent application WO 02/062132, or EP 2489286A.
- the water insoluble polyvalent metal salt is preferably formed from an organic acid, especially higher saturated or unsaturated fatty acids, in particular those having 18 or more carbon atoms, e.g., stearic acid and oleic acid, or polycarboxylic acids, especially e.g., alginic acid, oxalic acid.
- the water insoluble substrate or the fabric may comprise the water insoluble polyvalent metal salt fiber, especially calcium alginate fiber, in an amount ranging from 10%to 80%by weight, especially from 10%to 40%by weight, relative to the total weight of the water insoluble substrate or the fabric.
- the water insoluble substrate or the fabric may comprise the at least one other fiber in an amount ranging from 10%to 80%by weight, especially from 50%to 80%by weight, relative to the total weight of the water insoluble substrate or the fabric.
- a suitable nonwoven fabric comprising calcium alginate fiber is commercially available from the Sanjiang company under the name M762R-40CN.
- Embodiment 2 is a diagrammatic representation of Embodiment 1:
- the substrate may comprise a woven or nonwoven fabric consisting essentially of at least one fiber chosen from natural fibers such as cotton, pulp, bamboo and cellulose fibers, semi-natural fibers such as viscose rayon fibers, synthetic fibers such as polyester fibers, polyethylene terephthalate fibers, polyethylene fibers and polypropylene fibers.
- the at least one water insoluble salt of polyvalent metal is distributed as uniformly as possible in the substrate.
- the water insoluble salt of polyvalent metal is prepared into an aqueous dispersion, e.g., for water insoluble salt of calcium. Then, the dispersion is applied, e.g., through coating, spraying and the like, onto the substrate, so as to distribute uniformly the salt of calcium in the substrate in an amount sufficient to form a gel on the substrate with alginate.
- the wet substrate loaded with the aqueous salt is subsequently dried.
- the method to dry the tissue is not limited specifically. For industrial application, the wet substrate is dried in an economically effective manner.
- water insoluble salt of polyvalent metal such as the salt of calcium, e.g., as water insoluble salt, in solid form is crushed into powder or particles, e.g., through milling, grinding and the like. Then, the powder or particle is applied uniformly onto the substrate.
- the diameter of the powder or particle is not limited specifically, as long as the water insoluble salt of polyvalent metal can be distributed uniformly in the substrate in an amount sufficient to form a gel on the substrate with alginate.
- the water insoluble polyvalent metal salt is preferably formed from an inorganic acid, e.g., one selected from the group consisting of sulfonic acid, carbonic acid, phosphoric acid meta-aluminic acid, silicic acid, preferably sulfonic acid.
- an inorganic acid e.g., one selected from the group consisting of sulfonic acid, carbonic acid, phosphoric acid meta-aluminic acid, silicic acid, preferably sulfonic acid.
- the water insoluble substrate or the fabric may comprise the water insoluble polyvalent metal salt, especially calcium salt, in an amount ranging from 0.01%to 5%by weight, preferably from 0.02%to 1%by weight, or preferably from 0.04%to 0.5%by weight, relative to the total weight of the water insoluble substrate or the fabric.
- the water soluble polyhydroxy polymer is preferably combined with the water insoluble substrate.
- the process to combine the water soluble polyhydroxy polymer with the water insoluble substrate is not limited specifically, as long as the water soluble polyhydroxy polymer can be distributed uniformly in the substrate in an amount sufficient to soften the substrate to the desirable extent.
- the water soluble polyhydroxy polymer is prepared into an aqueous solution. Then, the water soluble polyhydroxy polymer is loaded onto the substrate, e.g., a mask tissue.
- the water soluble polyhydroxy polymer is prepared into a suspension or paste, e.g., a water soluble water soluble polyhydroxy polymer suspended in or mixed with a medium other than water to form a suspension or paste thereof. Then, the suspension or paste is applied, e.g., through coating, spraying and the like, onto the substrate, so as to distribute uniformly the water soluble polyhydroxy polymer in the substrate in an amount sufficient to form a gel on the substrate with alginate.
- a suspension or paste e.g., a water soluble water soluble polyhydroxy polymer suspended in or mixed with a medium other than water to form a suspension or paste thereof.
- the suspension or paste is applied, e.g., through coating, spraying and the like, onto the substrate, so as to distribute uniformly the water soluble polyhydroxy polymer in the substrate in an amount sufficient to form a gel on the substrate with alginate.
- the wet substrate loaded with the aqueous salt is subsequently dried.
- the method to dry the tissue is not limited specifically.
- the wet substrate is dried in an economically effective manner.
- the water soluble polyhydroxy polymer in solid form is crushed into powder or particles, e.g., through milling, grinding and the like. Then, the powder or particle is applied uniformly onto the substrate.
- the diameter of the powder or particle is not limited specifically, as long as the water soluble polyhydroxy polymer can be distributed uniformly in the substrate in an amount sufficient to soften the substrate.
- the water insoluble substrate or the fabric may comprise the water soluble polyhydroxy polymer, e.g., HEC or HPC, in an amount ranging from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, relative to the total weight of the, relative to the total weight of the water insoluble substrate or the fabric.
- HEC water soluble polyhydroxy polymer
- HPC water soluble polyhydroxy polymer
- the kit according to the present invention comprises, separate from and isolated with the first composition (e.g. the water insoluble substrate) , a second composition.
- the second composition as needed, impregnates, coats or is otherwise in contact with the first composition, so as to transform the texture of the first composition, for example, from tissue to gel.
- the weight ratio of the first composition (e.g. the water insoluble substrate or the fabric) to the second composition ranges from 1: 3 to 1: 20, preferably from 1: 8 to 1: 15.
- the second composition of the present invention at least comprises a) optionally, at least one water soluble chelating agent of the polyvalent metal ion and b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion.
- the water insoluble polyvalent metal ion donator reacts with salt in solution and releases the polyvalent metal ions.
- the second composition does not comprise component a) , i.e., the at least one water soluble chelating agent of the polyvalent metal ion
- the polyvalent metal ions released into solution react with component b) , i.e., the at least one water soluble gelatinizing agent, directly.
- component a) i.e., the at least one water soluble chelating agent of the polyvalent metal ion
- the polyvalent metal ions released into solution react with component b) , i.e., the at least one water soluble gelatinizing agent, directly.
- component a) most of the polyvalent metal ions released into solution would be trapped by the water soluble chelating agent. A few of free polyvalent metal ions in the solution react with the water soluble gelatinizing agent and start to gelatinize on the tissue surface.
- the chelated polyvalent metal ions would be gradually released and then gelatinize on the tissue surface. After a short period of time, transformation of tissue texture and a homogeneous gel on the tissue surface would be observed.
- the second composition according to the present invention comprises optionally component a) , i.e., at least one water soluble chelating agent of the polyvalent metal ion, to facilitate the texture transformation, and specially, to boost at least the moisture or actives delivery capacity.
- the water soluble chelating agent of the polyvalent metal ion is water-soluble.
- the water insoluble polyvalent metal ion donator releases few or more of the polyvalent metal ions into solution.
- Both the chelating agent of the polyvalent metal ion and the water soluble gelatinizing agent are capable of being combined with the polyvalent metal ions.
- the specific chelating agent according to the present invention conquers the gelatinizing agent in the competition of combination with the polyvalent metal ion, such that most of polyvalent metal ions released are trapped by the water soluble chelating agent. There are still a few of free polyvalent metal ions in the solution to react with the water soluble gelatinizing agent and start to gelatinize on the tissue surface. As the concentration of free polyvalent metal ions decreases over time, the chelated polyvalent metal ions would be gradually released and then gelatinize on the tissue surface. That is, the specific chelating agent according to the present invention serves as a reservoir of the polyvalent metal ions for the gelatinization on the tissue surface.
- the useful chelating agent of the polyvalent metal ion comprises aminocarboxylic acids, e.g., elhylenediamine tetraacetic acid (EDTA) , aminotriacetic acid, diethylene triaminepentaacetic acid, and in particular the alkali metal salt thereof, e.g., N, N-bis (carboxymethyl) glutamic acid, tetrasodium EDTA, tetrasodium salt of N, N-bis (carboxymethyl) glutamic acid (glutamic acid diacetic acid, GLDA) ; hydroxy carboxylic acids, e.g., citric acid, tartaric acid, glucuronic acid, succinic acid, ethylenediamine disuccinic acid (EDDS) , and in particular the alkali metal salt thereof; hydroxy aminocarboxylic acids, e.g., hydroxyethylethylenediamine triacetic acid (HEDTA) , dihydroxy
- EDTA
- the at least one water soluble chelating agent of the polyvalent metal ion is an alkali metal hydroxy polycarboxylate represented by an alkane containing from 1 to 4 carbon atoms, preferably containing 2 or 3 carbon atoms, substituted by 1, 2, or 3 hydroxy groups (-OH) , preferably by one (1) hydroxy group, and further substituted by 2, 3, 4 or 5 carboxylate groups (-COOM) , preferably by 2 or 3 carboxylate groups (-COOM) , wherein the multiple groups M independently represent H or alkali metal, with the proviso that at least one of the groups M represents alkali metal, such as Na, K or Li, preferably all groups M represent alkali metal, such as Na, K or Li, preferably Na.
- alkali metal hydroxy polycarboxylate represented by an alkane containing from 1 to 4 carbon atoms, preferably containing 2 or 3 carbon atoms, substituted by 1, 2, or 3 hydroxy groups (-OH) , preferably by one (1) hydroxy
- the at least one alkali metal hydroxy polycarboxylate may be chosen from sodium tartrates, sodium citrates, potassium tartrates, potassium citrates, and hydrates thereof, preferably sodium citrates, in particularly trisodium citrate.
- sodium citrates are used to indicate monosodium citrate, disodium citrate and trisodium citrate, and other alkali metal hydroxy polycarboxylates may be understood in a similar way.
- the alkali metal mentioned above is preferably sodium or potassium, in particular sodium.
- preferable chelating agents can comprise sodium citrate, tetrasodium EDTA, tetrasodium GLDA, trisodium EDDS, sodium phytate, or a mixture thereof.
- the second composition of the present invention may comprise the at least one water soluble chelating agent of the polyvalent metal ion in a content ranging from 0.1%to 1%by weight, especially from 0.2%to 0.4%by weight, relative to the total weight of the second composition.
- the second composition according to the present invention comprises at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion, to trigger the texture transformation.
- water soluble gelatinizing agent specifically means one gelatinizable with the polyvalent metal ion from the first composition.
- the water insoluble polyvalent metal ion donator releases few or more of the polyvalent metal ions into solution.
- the gelatinizing agent can thus be anyone gelatinizable with the polyvalent metal ion.
- the gelatinizing agent can comprise glutins, pectins, gellan gum, carrageenans, agars, alginic compounds and in particular alkali metal salts of alginic acid, e.g., sodium alginate, and mixtures thereof.
- the gelatinizing agent and the chelating agent are both specifically selected where the gelatinizing agent has an ability of combining with the polyvalent metal ions lower than that of the chelating agent, such that the gelatinizing agent does not combine the free polyvalent metal ions released directly from the first composition, but combines with the polyvalent metal ions subsequently from the reservoir, i.e., the chelated polyvalent metal ions. Accordingly, a gel on the surface of the first composition can be formed.
- Pectins are linear polymers of ⁇ -D-galacturonic acid (at least 65%) linked in positions 1 and 4 with a certain proportion of carboxylic groups esterified with a methanol group. About 20%of the sugars constituting the pectin molecule are neutral sugars (L-rhamnose, D-glucose, D-galactose, L-arabinose, D-xylose) . L-Rhamnose residues are found in all pectins, incorporated into the main chain in positions 1, 2.
- Uronic acid molecules bear carboxyl functions. This function gives pectins the capacity for exchanging ions, when they are in COO - form. Divalent ions (in particular calcium) have the capacity of forming ionic bridges between two carboxyl groups of two different pectin molecules.
- a certain proportion of the carboxylic groups are esterified with a methanol group.
- the natural degree of esterification of a pectin may range between 70%(apple, lemon) and 10% (strawberry) depending on the source used.
- pectins with a high degree of esterification it is possible to hydrolyse the-COOCH 3 groups, so as to obtain weakly esterified pectins.
- the chain is thus more or less acidic.
- HM (high-methoxy) pectins are thus defined as having a degree of esterification of greater than 50%
- LM (low-methoxy) pectins are defined as having a degree of esterification of less than 50%.
- the-OCH 3 group is substituted with a -NH 2 group.
- Pectins are especially sold by the company Cargill under the name Unipectine TM , by the company CP-Kelco under the name Genu, and by Danisco under the name Grinsted Pectin.
- Carrageenans are anionic polysaccharides constituting the cell walls of various red algae (Rhodophyceae) belonging to the Gigartinacae, Hypneaceae, Furcellariaceae and Polyideaceae families. They are generally obtained by hot aqueous extraction from natural strains of said algae. These linear polymers, formed by disaccharide units, are composed of two D-galactopyranose units linked alternately by ⁇ (1, 3) and ⁇ (1, 4) bonds. They are highly sulfated polysaccharides (20-50%) and the ⁇ -D-galactopyranosyl residues may be in 3, 6-anhydro form.
- carrageenans which bear one sulfate-ester group
- iota-carrageenans which bear two sulfate-ester groups
- lambda-carrageenans which bear three sulfate-ester groups.
- Carrageenans are composed essentially of potassium, sodium, magnesium, triethanolamine and/or calcium salts of polysaccharide sulfate esters.
- Carrageenans are sold especially by the company SEPPIC under the name by the company Gelymar under the names and by the company Cargill, under the names Satiagel TM and Satiagum TM , and by the company CP-Kelco under the names and
- Agars are galactose polysaccharides contained in the cell wall of some of these species of red algae (rhodophyceae) . They are formed from a polymer group whose base backbone is a ⁇ (1, 3) D-galactopyranose and ⁇ (1, 4) L 3-6 anhydrogalactose chain, these units repeating regularly and alternately. The differences within the agar family are due to the presence or absence of solvated methyl or carboxyethyl groups. These hybrid structures are generally present in variable percentage, depending on the species of algae and the harvest season.
- Agar-agar is a mixture of polysaccharides (agarose and agaropectin) of high molecular mass, between 40000 and 300000 g. mol -1 . It is obtained by manufacturing algal extraction liquors, generally by autoclaving, and by treating these liquors which comprise about 2%of agar-agar, so as to extract the latter.
- Agar is produced, for example, by the group B&V Agar Producers under the names Gold Agar, Agarite and Grand Agar by the company Hispanagar, and under the names Agar-Agar, QSA (Quick Soluble Agar) , and Puragar by the company Setexam.
- Gellan gum is an anionic linear heteropolyoside based on oligoside units composed of 4 saccharides (tetra-oside) .
- D-Glucose, L-rhamnose and D-glucuronic acid in 2: 1: 1 proportions are present in gellan gum in the form of monomer elements.
- Kelcogel CG LA It is sold, for example, under the name Kelcogel CG LA by the company CP Kelco.
- the gelatinizing agent is preferably chosen from alkali metal alginic compounds.
- the particularly preferable gelatinizing agent is alginate, e.g., sodium or potassium alginate, especially sodium alginate.
- the at least one water soluble gelatinizing agent is present in the second composition from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, relative to the total weight of the second composition.
- the amounts of the chelating agent and the gelatinizing agent are so selected that the molar ratio of the moiety to be released from the chelating agent chelatable with the polyvalent cation to the moiety to be released from the gelatinizing agent gelatinizable with the polyvalent cation ranging from about 10: 1 to about 1: 1, preferably from about 5: 1 to about 2: 1.
- alkali metal alginic compound in particular means alkali metal alginic acid salts (alginates) or alkali metal salts of alginic acid derivatives.
- the alkali metal alginic compound is water-soluble.
- Alginic acid a natural substance obtained from brown algae or from certain bacteria, is a polyuronic acid composed of two uronic acids linked together via 1, 4-glycoside bonds: ⁇ -D-mannuronic acid (M) and ⁇ -L-glucuronic acid (G) .
- Alginic acid is capable of forming water-soluble salts (alginates) with alkali metals such as sodium, potassium or lithium. These alginates are water-soluble in aqueous medium at pH 4 but dissociate into alginic acid at a pH below 4.
- Alginic acid or alginates may be chemically modified, especially with urea or urethane groups or by hydrolysis, oxidation, esterification, etherification, sulfatation, phosphatation, amination, amidation or alkylation reaction, or by several of these modifications, forming alginic acid derivatives, including salts.
- These derivatives may be anionic, cationic, amphoteric or nonionic, and are capable of forming water-soluble salts with an alkali metal such as sodium, potassium or lithium, forming alkali metal salts of alginic acid derivatives.
- alginates may be reacted with an alkylene oxide, such as ethylene oxide or propylene oxide, to form polyglycol alginates.
- the polyglycol segment is bonded to alginates through the carboxyl group (s) .
- alginates react with propylene oxide to form polypropylene glycol alginates (PPG alginates)
- PPG alginates polypropylene glycol alginates
- PEG alginates polyethylene glycol alginates
- Preparation of polyglycol alginates is disclosed in Strong, U.S. Pat. No. 3,948,881, Pettitt, U.S. Pat. No. 3,772,266, and Steiner, U.S. Pat. No. 2,426,125.
- the polyglycol alginate has a degree of esterification of about 40%to about 95%, more preferably about 70%to 95%.
- Suitable alginates have a weight-average molecular weight of about 20,000 Daltons to about 500,000 Daltons.
- the weight-average molecular weight is calculated by first determining the intrinsic viscosity, then using the Mark-Houwink Sakurada Equation, as in Martinsen, et al, "Comparison of Different Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates" (Carbohydr. Polym., 15, 171-193, 1991) .
- weight-average molecular weights indicated above are also valid for the alkali metal salts of alginic acid derivatives.
- the alkali metal alginic compound may be chosen from sodium alginate and potassium alginate, preferably sodium alginate.
- alkali metal alginic compounds that are suitable for use in the present invention may be represented, for example, by the products sold under the names Kelcosol, Satialgine TM , Cecalgum TM or Algogel TM by the company Cargill Products, under the name Protanal TM by the company FMC Biopolymer, under the name Alginate by the company Danisco, under the name Kimica Algin by the company Kimica, and under the names and by the company ISP.
- the second composition according to the present invention comprises at least one aqueous phase.
- the at least one aqueous phase comprises water.
- the aqueous phase may also comprise water-miscible organic solvents (at room temperature: 25°C) , for instance monoalcohols containing from 2 to 6 carbon atoms, such as ethanol or isopropanol; polyols especially containing from 2 to 20 carbon atoms, preferably containing from 2 to 10 carbon atoms and preferentially containing from 2 to 6 carbon atoms, such as glycerol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol or diethylene glycol; glycol ethers (especially containing from 3 to 16 carbon atoms) such as mono-, di- or tri-propylene glycol (C 1 -C 4 ) alkyl ethers, mono-, di- or tri-ethylene glycol (C 1 -C 4 ) alkyl ethers, and mixtures thereof.
- monoalcohols containing from 2 to 6 carbon atoms, such as ethanol or is
- the aqueous phase may also comprise any water-soluble or water-dispersible compound that is compatible with an aqueous phase, such as hydrophilic gelling agents, preservatives or surfactants, and mixtures thereof.
- the second composition of the present invention may comprise the at least one aqueous phase in a content ranging from 10%to 99%by weight, especially from 50%to 99%by weight, and more particularly from 70%to 99%by weight, relative to the total weight of the second composition.
- the second composition according to the present invention may comprise optionally at least one additional hydrophilic gelling agent.
- hydrophilic gelling agent means a compound that is capable of gelling the aqueous phase, without combining with the polyvalent metal ions from the first composition.
- the gelling agent may be water-soluble or water-dispersible.
- hydrophilic gelling agent may be chosen from synthetic polymeric gelling agents, polymeric gelling agents that are natural or of natural origin, or a mixture thereof.
- the term "synthetic" means that the polymer is neither naturally existing nor a derivative of a polymer of natural origin.
- the synthetic polymeric gelling agent under consideration according to the present invention may or may not be particulate.
- the term "particulate" when being used for the synthetic polymeric gelling agent, means that the polymer is in the form of particles, preferably spherical particles.
- these polymers may be chosen especially from:
- modified or unmodified carboxyvinyl polymers such as the products sold under the name (CTFA name: Carbomer) by the company Goodrich; polyacrylates, polymethacrylates such as the products sold under the names Lubrajel TM and Norgel by the company Guardian or under the name by the company Hispano Chimica; polyacrylamides; optionally crosslinked and/or neutralized 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, for instance the poly (2-acrylamido-2-methylpropanesulfonic acid) sold by the company Clariant under the name Hostacerin (CTFA name: ammonium polyacryldimethyltauramide) ; crosslinked anionic copolymers of acrylamide and of which are in the form of a W/O emulsion, such as those sold under the name Sepigel TM 305 (CTFA name: Polyacrylamide/C 13-14 isoparaffin/Laureth-7) and under the name Simulgel TM 600 (CTFA name: Acryl
- these polymers may be chosen from Acrylates/C 10-30 Alkyl Acrylate Crosspolymer such as, ultrez 20, ultrez 21, Permulen TM TR-1, Permulen TM TR-2, 1382, ETD 2020, Carbomer such as K, 980, Ammonium acryloyldimethyl Taurate/Steareth-8 Methacrylate copolymer such as SNC, Acrylates copolymer such as Aqua SF-1, Ammonium acryloyldimethyl taurate/steareth-25 Methacrylate Crosspolymer such as HMS, Ammonium acryloyldimethyl taurate such as AVC.
- Acrylates/C 10-30 Alkyl Acrylate Crosspolymer such as, ultrez 20, ultrez 21, Permulen TM TR-1, Permulen TM TR-2, 1382, ETD 2020, Carbomer such as K, 980, Ammonium acryloyldimethyl Taurate/Steareth-8 Methacrylate cop
- these polymers may be chosen from carboxyvinyl polymers such as the products (carbomers) such as Ultrez 20 Polymer marketed by Lubrizol and the Pemulen products (acrylate/C 10-30 alkylacrylate copolymer) ; polyacrylamides, for instance the crosslinked copolymers marketed under the trademarks Sepigel TM 305 (CTFA name: polyacrylamide/C 13-14 isoparaffin/Laureth-7) or Simulgel TM 600 (CTFA name: acrylamide/sodium acryloyldimethyltaurate copolymer/isohexadecane/polysorbate 80) by SEPPIC; 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, which are optionally crosslinked and/or neutralized, for instance the poly (2-acrylamido-2-methylpropanesulfonic acid) marketed by Hoechst under the trademark Hostacerin (CTFA name: ammonium polyacryloyldi
- these polymers may be chosen from glyceryl acrylate/acrylic acid copolymers available from ISP Technologies, Inc. (United Guardian Inc. ) under the tradename Lubrajel TM , particular the form known as Lubrajel TM oil which contains about 1.0%-1.3%glyceryl acrylate/acrylic acid copolymer in aqueous glycerin (about 40%glycerin) .
- Lubrajel TM oil also includes about 0.6%PVM/MA copolymer (also known as methoxyethylene/maleic anhydride copolymer) .
- the term "of natural origin” is intended to denote polymeric gelling agents obtained by modification of natural polymeric gelling agents.
- These gelling agents may be particulate or non-particulate.
- these gelling agents fall within the category of polysaccharides.
- polysaccharides that are suitable for use in the present invention may be homopolysaccharides such as fructans, glucans, galactans and mannans or heteropolysaccharides such as hemicellulose.
- they may be linear polysaccharides such as pullulan or branched polysaccharides such as gum arabic and amylopectin, or mixed polysaccharides such as starch.
- the polysaccharides may be chosen from ones produced by microorganisms; polysaccharides isolated from algae, and higher plant polysaccharides, such as homogeneous polysaccharides, in particular celluloses and derivatives thereof or fructosans, heterogeneous polysaccharides such as gum arables, galactomannans, glucomannans, and derivatives thereof; and mixtures thereof.
- the polysaccharides may be chosen from fructans, gellans, glucans, amylose, amylopectin, glycogen, pullulan, dextrans, celluloses and derivatives thereof, in particular methylcelluloses, hydroxyalkylcelluloses, ethylhydroxyethylcelluloses and carboxymethylcelluloses, mannans, xylans, lignins, arabans, galactans, galacturonans, chitin, chitosans, glucuronoxylans, arabinoxylans, xyloglucans, glucomannans, arabinogalactans, glycosaminoglucans, gum arables, tragacanth gums, ghatti gums, locust bean gums, galactomannans such as guar gums and nonionic derivatives thereof, in particular hydroxypropyl guar, and ionic derivatives thereof, biopoly saccharide gums of microbial origin, in particular
- polysaccharides may be chemically modified, especially with urea or urethane groups or by hydrolysis, oxidation, esterification, etherification, sulfatation, phosphatation, amination, amidation or alkylation reaction, or by several of these modifications.
- the derivatives obtained may be anionic, cationic, amphoteric or nonionic.
- the polysaccharides may be chosen from xanthan gum, scleroglucan gum, guar gum, inulin and pullulan, and mixtures thereof.
- the compounds of this type that may be used in the present invention are chosen from those described especially in Kirk-Othmer's Encyclopedia of Chemical Technology, Third Edition, 1982, volume 3, pp. 896-900, and volume 15, pp. 439-458, in Polymers in Nature by E.A. MacGregor and C.T. Greenwood, published by John Wiley&Sons, Chapter 6, pp. 240-328, 1980, in the book by Robert L. Davidson entitled Handbook of Water-Soluble Gums and Resins published by McGraw Hill Book Company (1980) and in Industrial Gums-Polysaccharides and their Derivatives, edited by Roy L. Whistler, Second Edition, published by Academic Press Inc.
- these polysaccharides that are suitable for use in the present invention may be distinguished according to whether they are derived from microorganisms, from algae or from higher plants, and are detailed below.
- Xanthan is a heteropolysaccharide produced at the industrial scale by the aerobic fermentation of the bacterium Xanthomonas campestris. Its structure consists of a main chain of ⁇ (1, 4) -linked ⁇ -D-glucoses, similar to cellulose. One glucose molecule in two bears a trisaccharide side chain composed of an ⁇ -D-mannose, a ⁇ -D-glucuronic acid and a terminal ⁇ -D-mannose. The internal mannose residue is generally acetylated on carbon 6. About 30%of the terminal mannose residues bear a pyruvate group linked in chelated form between carbons 4 and 6.
- the charged pyruvic acids and glucuronic acids are ionizable, and are thus responsible for the anionic nature of xanthan (negative charge down to a pH equal to 1) .
- the content of pyruvate and acetate residues varies according to the bacterial strain, the fermentation process, the conditions after fermentation and the purification steps. These groups may be neutralized in commercial products with Na + , K + or Ca 2+ ions (Satia company, 1986) .
- the neutralized form may be converted into the acid form by ion exchange or by dialysis of an acidic solution.
- Xanthan gums have a molecular weight of between 1 000 000 and 50 000 000 and a viscosity of between 0.6 and 1.65 Pa. s for an aqueous composition containing 1%of xanthan gum (measured at 25°C on a Brookfield viscometer of LVT type at 60 rpm) .
- Xanthan gums are represented, for example, by the products sold under the names Rhodicare by the company Rhodia Chimie, under the name Satiaxane TM by the company Cargill Texturizing Solutions (for the food, cosmetic and pharmaceutical industries) , under the name Novaxan TM by the company ADM, and under the names and by the company CP-Kelco.
- Pullulan is a polysaccharide consisting of maltotriose units, known under the name ⁇ (1, 4) - ⁇ (1, 6) -glucan. Three glucose units in maltotriose are connected via an ⁇ (1, 4) glycoside bond, whereas the consecutive maltotriose units are connected to each other via an ⁇ (1, 6) glycoside bond.
- Pullulan is produced, for example, under the reference Pullulan PF 20 by the group Hayashibara in Japan.
- Dextran is a neutral polysaccharide not bearing any charged groups, which is biologically inert, prepared by fermentation of beet sugar containing solely hydroxy groups. It is possible to obtain dextran fractions of different molecular weights from native dextran by hydrolysis and purification. Dextran may in particular be in the form of dextran sulfate.
- Dextran is represented, for example, by the products sold under the name Dextran or Dextran T by the company Pharmacosmos, or under the name Dextran 40 Powder or Dextran 70 Powder by the company Meito Sangyo Co.
- Dextran sulfate is sold by the company PK Chemical A/S under the name Dextran sulfate.
- Succinoglycan is an extracellular polymer of high molecular weight produced by bacterial fermentation, consisting of octasaccharide repeating units (repetition of 8 sugars) .
- Succinoglycans are sold, for example, under the name Rheozan by the company Rhodia. Scleroglucan
- Scleroglucan is a nonionic branched homopolysaccharide consisting of ⁇ -D-glucan units.
- the molecules consist of a linear main chain formed from D-glucose units linked via ⁇ (1, 3) bonds and of which one in three is linked to a side D-glucose unit via a ⁇ (1, 6) bond.
- Scleroglucan is sold, for example, under the name Amigel by the company Alban Miiller, or under the name Actigum TM CS by the company Cargill.
- Furcellaran is obtained commercially from red algae Furcellaria fasztigiata. Furcellaran is produced, for example, by the company Est-Agar.
- This category of polysaccharides may be divided into homogeneous polysaccharides (only one saccharide species) and heterogeneous polysaccharides composed of several types of saccharides.
- the polysaccharide according to the present invention may be chosen from celluloses and derivatives or fructosans.
- the polysaccharide according to the present invention may also be a cellulose or a derivative thereof, especially cellulose ethers or esters (e.g. methylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxymethylpropylcellulose, cellulose acetate, cellulose nitrate, nitrocellulose) .
- cellulose ethers or esters e.g. methylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxymethylpropylcellulose, cellulose acetate, cellulose nitrate, nitrocellulose
- the present invention may also contain a cellulose-based associative polymer.
- the repeating unit is the cellobiose dimer.
- the AGUs are in chair conformation and bear 3 hydroxy functions: 2 secondary alcohols (in position 2 and 3) and a primary alcohol (in position 6) .
- the polymers thus formed combine together via intermolecular bonds of hydrogen bond type, thus giving the cellulose a fibrillar structure (about 1500 molecules per fibre) .
- the degree of polymerization differs enormously depending on the origin of the cellulose; its value may range from a few hundred to several tens of thousands.
- the hydroxy groups of cellulose may react partially or totally with various chemical reagents to give cellulose derivatives having intrinsic properties.
- the cellulose derivatives may be anionic, cationic, amphoteric or nonionic.
- cellulose ethers, cellulose esters and cellulose ester ethers are distinguished.
- nonionic cellulose ethers mention may be made of alkylcelluloses such as methylcelluloses and ethylcelluloses; hydroxyalkylcelluloses such as hydroxymethylcelluloses, hydroxyethylcelluloses and hydroxypropylcelluloses; and mixed hydroxyalkylalkylcelluloses such as hydroxypropylmethylcelluloses, hydroxy-ethylmethylcelluloses, hydroxy ethylethylcelluloses and hydroxybutylmethylcelluloses.
- alkylcelluloses such as methylcelluloses and ethylcelluloses
- hydroxyalkylcelluloses such as hydroxymethylcelluloses, hydroxyethylcelluloses and hydroxypropylcelluloses
- mixed hydroxyalkylalkylcelluloses such as hydroxypropylmethylcelluloses, hydroxy-ethylmethylcelluloses, hydroxy ethylethylcelluloses and hydroxybutylmethylcelluloses.
- the hydroxyalkylcellulose as a nonionic cellulose ether, belongs to the category of nonionic polysaccharide, such that it can be useful as the water soluble polyhydroxy polymerto soften fibers rich in hydroxy groups.
- the first composition comprises fibers rich in hydroxy groups
- the second composition comprises hydroxyalkylcelluloses.
- anionic cellulose ethers mention may be made of carboxyalkylcelluloses and salts thereof.
- cationic cellulose ethers mention may be made of crosslinked or non-crosslinked, quaternized hydroxyethylcelluloses.
- the quaternizing agent may in particular be glycidyltrimethylammonium chloride or a fatty amine such as laurylamine or stearylamine.
- a fatty amine such as laurylamine or stearylamine.
- Another cationic cellulose ether that may be mentioned is hydroxy ethylcellulosehydroxypropyltrimethylammonium.
- the quaternized cellulose derivatives are, in particular:
- - quaternized celluloses modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof,
- - quaternized hydroxyethylcelluloses modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof.
- the alkyl radicals borne by the above quaternized celluloses or hydroxyethylcelluloses preferably contain from 8 to 30 carbon atoms.
- the aryl radicals preferably denote phenyl, benzyl, naphthyl or anthryl groups.
- Examples of quaternized alkylhydroxyethylcelluloses containing C 8-30 fatty chains that may be indicated include the products Quatrisoft LM 200, Quatrisoft LM-X 529-18-A, Quatrisoft LM-X 529-18B (C 12 alkyl) and Quatrisoft LM-X 529-8 (C 18 alkyl) sold by the company Amerchol and the products Crodacel QM, Crodacel QL (C 12 alkyl) and Crodacel QS (C 18 alkyl) sold by the company Croda.
- - celluloses modified with groups comprising at least one fatty chain for instance hydroxyethylcelluloses modified with groups comprising at least one fatty chain, such as alkyl groups, especially of C 8-22 , arylalkyl and alkylaryl groups, such as Natrosol Plus Grade 330 CS (C 16 alkyls) sold by the company Aqualon, and
- polyalkylene glycol alkylphenyl ether groups such as the product Amercell Polymer HM-1500 (nonylphenyl polyethylene glycol (15) ether) sold by the company Amerchol.
- cellulose esters are mineral esters of cellulose (cellulose nitrates, sulfates, phosphates, etc. ) , organic cellulose esters (cellulose monoacetates, triacetates, amidopropionates, acetatebutyrates, acetatepropionates and acetatetrimellitates, etc. ) , and mixed organic/mineral esters of cellulose, such as cellulose acetatebutyrate sulfates and cellulose acetatepropionate sulfates.
- cellulose ester ethers mention may be made of hydroxypropylmethylcellulose phthalates and ethylcellulose sulfates.
- the cellulose-based compounds of the present invention may be chosen from unsubstituted celluloses and substituted celluloses.
- the celluloses and derivatives are represented, for example, by the products sold under the names (microcrystalline cellulose, MCC) by the company FMC Biopolymers, under the name Cekol (carboxymethylcellulose) by the company Noviant (CP-Kelco) , under the name Akucell AF(sodium carboxymethylcellulose) by the company Akzo Nobel, under the name Methocel TM (cellulose ethers) and Ethocel TM (ethylcellulose) by the company Dow, and under the names (carboxymethylcellulose and sodium carboxymethylcellulose) , (methylcellulose) , Blanose TM (carboxymethylcellulose) , (methylcellulose, hydroxypropylmethylcellulose) , (hydroxypropylcellulose) , (cetylhydroxyethylcellulose) and CS (hydroxy ethylcellulose) by the company Hercules Aqualon.
- the polysaccharide according to the present invention may especially be a fructosan chosen from inulin and derivatives thereof (especially dicarboxy and carboxymethyl inulins) .
- Fructans or fructosans are oligosaccharides or polysaccharides comprising a sequence of anhydrofructose units optionally combined with several saccharide residues other than fructose.
- Fructans may be linear or branched.
- Fructans may be products obtained directly from a plant or microbial source or alternatively products whose chain length has been modified (increased or decreased) by fractionation, synthesis or hydrolysis, in particular enzymatic.
- Fructans generally have a degree of polymerization from 2 to about 1000 and preferably from 2 to about 60.
- the first group corresponds to products whose fructose units are for the most part linked via ⁇ (2, 1) bonds. These are essentially linear fructans such as inulins.
- the second group also corresponds to linear fructoses, but the fructose units are essentially linked via ⁇ (2, 6) bonds. These products are levans.
- the third group corresponds to mixed fructans, i.e. containing ⁇ (2, 6) and ⁇ (2, 1) sequences. These are essentially branched fructans, such as graminans.
- the preferred fructans in the compositions according to the present invention are inulins.
- Inulin may be obtained, for example, from chicory, dahlia or Jerusalem artichoke, preferably from chicory.
- the polysaccharide especially the inulin, has a degree of polymerization from 2 to about 1000 and preferably from 2 to about 60, and a degree of substitution of less than 2 on the basis of one fructose unit.
- the inulin used for the present invention is represented, for example, by the products sold under the name Beneo TM inulin by the company Orafti, and under the name by the company Sensus.
- the polysaccharides that may be used according to the present invention may be gums, for instance cassia gum, karaya gum, konjac gum, gum tragacanth, tara gum, acacia gum or gum arabic.
- Gum arabic is a highly branched acidic polysaccharide which is in the form of mixtures of potassium, magnesium and calcium salts.
- the monomer elements of the free acid (arabic acid) are D-galactose, L-arabinose, L-rhamnose and D-glucuronic acid.
- Galactomannans guar, locust bean, fenugreek, tara gum
- derivatives guar phosphate, hydroxypropyl guar, etc.
- Galactomannans are nonionic polyosides extracted from the endosperm of leguminous seeds, of which they constitute the storage carbohydrate.
- Galactomannans are macromolecules consisting of a main chain of ⁇ (1, 4) -linked D-mannopyranose units, bearing side branches consisting of a single D-galactopyranose unit ⁇ (1, 6) -linked to the main chain.
- the various galactomannans differ, firstly, by the proportion of ⁇ -D-galactopyranose units present in the polymer, and secondly, by significant differences in terms of distribution of galactose units along the mannose chain.
- the mannose/galactose (M/G) ratio is about 2 for guar gum, 3 for tara gum and 4 for locust bean gum.
- Guar gum is characterized by a mannose/galactose ratio of the order of 2/1.
- the galactose group is regularly distributed along the mannose chain.
- guar gums that may be used according to the present invention may be nonionic, cationic or anionic. According to the present invention, use may be made of chemically modified or unmodified nonionic guar gums.
- the unmodified nonionic guar gums are, for example, the products sold under the names Vidogum GH, Vidogum G and Vidocrem by the company Unipektin and under the name Jaguar by the company Rhodia, under the name Guar by the company Danisco, under the name Viscogum TM by the company Cargill, and under the name guar gum by the company Aqualon.
- hydrolysed nonionic guar gums that may be used according to the present invention are represented, for example, by the products sold under the name by the company Danisco.
- modified nonionic guar gums that may be used according to the present invention are preferably modified with C 1-6 hydroxyalkyl groups, among which mention may be made, for example, of hydroxymethyl, hydroxyethyl, hydroxypropyl and hydroxybutyl groups.
- nonionic guar gums optionally modified with hydroxyalkyl groups are sold, for example, under the trade names Jaguar HP 60, Jaguar HP 105 and Jaguar HP 120 (hydroxypropyl guar) by the company Rhodia or under the name HP (hydroxypropyl guar) by the company Aqualon.
- the cationic galactomannan gums preferably have a cationic charge density of less than or equal to 1.5 meq. /g, more particularly between 0.1 and 1 meq. /g.
- the charge density may be determined by the Kjeldahl method. It generally corresponds to a pH of the order of 3 to 9.
- cationic galactomannan gum means any galactomannan gum containing cationic groups and/or groups that can be ionized into cationic groups.
- the preferred cationic groups are chosen from those comprising primary, secondary, tertiary and/or quaternary amine groups.
- the cationic galactomannan gums used generally have a weight-average molecular mass of between 500 and 5 ⁇ 10 6 approximately and preferably between 10 3 and 3 ⁇ 10 6 approximately.
- the cationic galactomannan gums that may be used according to the present invention are, for example, gums comprising tri (C 1-4 ) alkylammonium cationic groups. Preferably, 2%to 30%by number of the hydroxy functions of these gums bear trialkylammonium cationic groups.
- trialkylammonium groups mention may be made most particularly of trimethylammonium and triethylammonium groups.
- these groups represent from 5%to 20%by weight relative to the total weight of the modified galactomannan gum.
- the cationic galactomannan gum is preferably a guar gum comprising hydroxypropyltrimethylammonium groups, i.e. a guar gum modified, for example, with 2, 3-epoxypropyltrimethylammonium chloride.
- galactomannan gums in particular guar gums modified with cationic groups are products already known per se and are, for example, described in patents US 3 589 578 and US 4 031 307.
- Such products are moreover sold especially under the trade names Jaguar EXCEL, Jaguar C13 S, Jaguar C 15, Jaguar C 17 and Jaguar CI 62 (Guar Hydroxypropyltrimonium Chloride) by the company Rhodia, under the name Guar (Guar Hydroxypropyltrimonium Chloride) by the company Degussa, and under the name 3000 (Guar Hydroxypropyltrimonium Chloride) by the company Aqualon.
- the anionic guar gums that may be used according to the present invention are polymers comprising groups derived from carboxylic, sulfonic, sulfenic, phosphoric, phosphonic or pyruvic acid.
- the anionic group is preferably a carboxylic acid group.
- the anionic group may also be in the form of an acid salt, especially a sodium, calcium, lithium or potassium salt.
- anionic guar gums that may be used according to the present invention are preferentially carboxymethyl guar derivatives (carboxymethyl guar or carboxymethyl hydroxypropyl guar) .
- Locust bean gum is extracted from the seeds of the locust bean tree Ceratonia siliqua) .
- the unmodified locust bean gum that may be used in the present invention is sold, for example, under the name Viscogum TM by the company Cargill, under the name Vidogum L by the company Unipektin and under the name LBG by the company Danisco.
- the chemically modified locust bean gums that may be used in the present invention may be represented, for example, by the cationic locust beans sold under the name Catinal CLB (locust bean hydroxypropyltrimonium chloride) by the company Toho.
- Catinal CLB locust bean hydroxypropyltrimonium chloride
- the tara gum that may be used in the context of the present invention is sold, for example, under the name Vidogum SP by the company Unipektin.
- Glucomannan is a polysaccharide of high molecular weight (500 000 ⁇ Mglucomannan ⁇ 2 000 000) composed of D-mannose and D-glucose units with a branch every 50 or 60 units approximately. It is found in wood, but is also the main constituent of konjac gum. Konjac (Amorphophallus konjac) is a plant of the Araceae family.
- chitin poly-N-acetyl-D-glucosamine, ⁇ (1, 4) -2-acetamido-2-deoxy-D-glucose
- chitosan and derivatives chitosan- ⁇ -glycerophosphate, carboxymethylchitin, etc.
- glycosaminoglycans such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, and preferably hyaluronic acid
- xylans or arabinoxylans
- Arabinoxylans are polymers of xylose and arabinose, all grouped under the name pentosans.
- Xylans consist of a main chain of ⁇ (1, 4) -linked D-xylose units and on which are found three substituents (Rouau&Thibault, 1987) : acid units, ⁇ -L-arabinofuranose units, side chains which may contain arabinose, xylose, galactose and glucuronic acid.
- the polysaccharide is preferably hyaluronic acid, or a salt thereof.
- the at least one hydrophilic gelling agent may be present in an amount ranging for example from 0.001 to 10%by weight, preferably 0.01 to 5%by weight and more preferably from 0.05 to 3%by weight relative to the total weight of the second composition.
- the first composition may comprise at least one active agent.
- the second composition may comprise at least one active agent.
- the first composition includes the at least one active agent
- it may be incorporated into the first composition in particular by means of an alternating electric field.
- the active agent (s) may be incorporated in particular in the powder state.
- ⁇ - or ⁇ -hydroxy acids such as lactic acid, glycolic acid, citric acid, 5-octanoylsalicyclic acid, ⁇ -hydroxydecanoic acid, ⁇ -hydroxylauric, tartaric acid, glucuronic acid, galacturonic acid, acrylic acid, ⁇ -hydroxybutyric acid, ⁇ -hydroxyisobutyric acid, malic acid, mandelic acid, phosphoric acid, pyruvic acid, lactobionic acid, and salicylic acid.
- ⁇ - or ⁇ -hydroxy acids such as lactic acid, glycolic acid, citric acid, 5-octanoylsalicyclic acid, ⁇ -hydroxydecanoic acid, ⁇ -hydroxylauric, tartaric acid, glucuronic acid, galacturonic acid, acrylic acid, ⁇ -hydroxybutyric acid, ⁇ -hydroxyisobutyric acid, malic acid, mandelic acid, phosphoric acid, pyruvic acid, lactobionic acid, and salicylic
- anti-acne agents such as salicylic acid or benzoyl peroxide, octopirox, dextrorotary and levorotary sulfur-containing amino acids, their salts, and their N-acetyl derivatives such as N-acetyl cysteine, or agents seeking to prevent aging of the skin and/or to improve its state, for example the above-mentioned ⁇ -and ⁇ -hydroxy acids, retinoids such as retinoic acid, retinol, and its esters, such as, for example, retinyl propionate, and retinyl acetate, or retinyl palmitate, niacinamide, allantoin, extracts of aloe, azelaic acid, bisabolol, phytic acid, collagen, or agents stimulating the formation of collagen, vitamins such as vitamin C or derivatives thereof, such as ascorbyl glucoside, vitamin E or derivatives thereof, vitamin A or derivatives thereof, vitamin
- active agents for improving the condition of the skin in the case of mask, such as moisturizers or agents serving to improve the natural lipid barrier, such as ceramides, cholesterol sulfates, and/or fatty acids, and mixtures thereof.
- active agents for improving the condition of the skin such as moisturizers or agents serving to improve the natural lipid barrier, such as ceramides, cholesterol sulfates, and/or fatty acids, and mixtures thereof.
- enzymes that have activity on the skin such as proteases, lipases, cerebrosidases, and/or melanases, and mixtures thereof.
- active agents there are agents for drugs, peptides, proteins, detectable labels, contrast reagents, pain-killing, anesthetics, antibacterial agents, anti-yeast agents, antifungal agents, antiviral agents, anti-dermititis agents, anti-pruritic agents, anti-emetics, vascular protectors, agents against motion sickness, anti-irritants, anti-inflammatory agents, immunomodulators, anti-hyperkeratolytic agents, agents for treating dry skin, antiperspirants, anti-psoriatic agents, antidandruff agents, anti-aging agents, anti-asthmatic agents and bronchodilators, sunscreen agents, antihiistamnes, healing agents, corticosteroids, tanning agents, and mixtures thereof.
- the content of the at least one active agent in the first composition and/or in the second composition may be adjusted as a function of the intended purpose of the kit.
- Hyaluronic compound may be also used as an active agent according to the present invention.
- the hyaluronic compound is preferably an alkali metal hyaluronic compound.
- alkali metal hyaluronic compound in particular means alkali metal salts of hyaluronic acid (hyaluronates) or derivatives thereof.
- the alkali metal hyaluronic compound is water-soluble.
- hyaluronic acid or derivatives thereof covers in particular the basic unit of hyaluronic acid of formula:
- hyaluronic acid comprising a disaccharide dimer, namely D-glucuronic acid and N-acetylglucosamine.
- hyaluronic acid or derivatives thereof also comprises, in the context of the present invention, the linear polymer comprising the polymeric unit described above, linked together in the chain via alternating ⁇ (1, 4) and ⁇ (1, 3) glycosidic linkages, having a molecular weight (Mw) that can range between 380 and 13 000 000 daltons. This molecular weight depends in large part on the source from which the hyaluronic acid is obtained and/or on the preparation methods.
- Mw molecular weight
- hyaluronic acid is present in pericellular gels, in the base substance of the connective tissues of vertebrate organs such as the dermis and epithelial tissues, and in particular in the epidermis, in the synovial fluid of the joints, in the vitreous humor, in the human umbilical cord and in the crista galli apophysis.
- hyaluronic acid or derivatives thereof comprises all the fractions or subunits of hyaluronic acid having a molecular weight in particular within the molecular weight range recalled above.
- the hyaluronic acid fractions suitable for the use covered by the present invention have a molecular weight of between 50 000 and 5 000 000, in particular between 100 000 and 5 000 000, especially between 400 000 and 5 000 000 Da.
- the term used is high-molecular-weight hyaluronic acid.
- the hyaluronic acid fractions that may also be suitable for the use covered by the present invention have a molecular weight of between 50 000 and 400 000 Da.
- the term used is intermediate-molecular-weight hyaluronic acid.
- the hyaluronic acid fractions that may be suitable for the use covered by the present invention have a molecular weight of less than 50 000 Da.
- the term used is low-molecular-weight hyaluronic acid.
- hyaluronic acid or derivatives thereof also comprises hyaluronic acid esters in particular those in which all or some of the carboxylic groups of the acid functions are esterified with oxyethylenated alkyls or alcohols, containing from 1 to 20 carbon atoms, in particular with a degree of substitution at the level of the D-glucuronic acid of the hyaluronic acid ranging from 0.5 to 50%.
- hyaluronic acid or hyaluronates may be reacted with an alkylene oxide, such as ethylene oxide or propylene oxide, to form polyglycol hyaluronates.
- alkylene oxide such as ethylene oxide or propylene oxide
- the polyglycol segment is bonded to hyaluronic acid through the carboxyl group (s) .
- hyaluronic acid or hyaluronates react with propylene oxide to form polypropylene glycol hyaluronates, while react with ethylene oxide to form polyethylene glycol hyaluronates.
- esters of hyaluronic acid include methyl, ethyl, n-propyl, n-pentyl, benzyl and dodecyl esters of hyaluronic acid. Such esters have in particular been described in D. Campoccia et al. "Semisynthetic resorbable materials from hyaluronan esterification” , Biomaterials 19 (1998) 2101-2127.
- the second composition of the present invention may also contain adjuvants that are common in cosmetics and/or dermatology, such as preserving agents, antioxidants, pH modifiers (acidic or basic) , fragrances, fillers, bactericides, odour absorbers, colorants (pigments and dyes) , emulsifiers, and also lipid vesicles.
- adjuvants that are common in cosmetics and/or dermatology, such as preserving agents, antioxidants, pH modifiers (acidic or basic) , fragrances, fillers, bactericides, odour absorbers, colorants (pigments and dyes) , emulsifiers, and also lipid vesicles.
- the second composition according to the present invention may be in various forms, in particular in the form of aqueous solution, dispersion, or emulsion, especially such as a water/oil or oil/water emulsion or multiple emulsions.
- An emulsion may have an oily or aqueous continuous phase.
- Such an emulsion may be, for example, an inverse (W/O) emulsion or a direct (O/W) emulsion, or alternatively a multiple emulsion (W/O/W or O/W/O) .
- the second composition according to the present invention may be in the form of an oil-in-water (O/W) emulsion, water-in-oil (W/O) emulsion, or a multiple emulsion, preferably a oil-in-water (O/W) emulsion.
- O/W oil-in-water
- W/O water-in-oil
- W/W multiple emulsion
- the second composition of the present invention is preferably an aqueous solution.
- the kit presents as a mask comprising:
- a nonwoven fabric made of fibers rich in hydroxy groups, comprising from 0.01%to 5%by weight, preferably from 0.02%to 1%by weight, or preferably from 0.04%to 0.5%, of calcium sulphate or calcium carbonate, and from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, of HEC or HPC, relative to the total weight of the nonwoven fabric, and
- composition comprising from 10%to 99%by weight, preferably from 50%to 99%by weight, of the at least one aqueous phase, from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, of sodium alginate, and from 0.1%to 0.5%by weight, preferably from 0.2%to 0.4%by weight, of sodium citrate, relative to the total weight of the composition,
- weight ratio of the nonwoven fabric to the composition ranges from 1: 3 to 1: 20, preferably from 1: 8 to 1: 15.
- a mask package 1 comprising:
- a first composition comprising at least one water insoluble salt of polyvalent metal and at least one water soluble polyhydroxy polymer
- first composition and the fourth composition are separately placed from one another.
- the first composition as well as the components thereof, including the water insoluble salt and the water soluble polyhydroxy polymer, and the fourth composition, including the water soluble chelating agent, the water soluble gelatinizing agent and others can be substantially same as the kit of the invention, where the fourth composition corresponds substantially to the second composition, except for the absence of water.
- the structure of the mask package 1 can be substantially same as the kit of the invention.
- the amounts of the compositions, the components of the compositions and the ratios therebetween of the mask package 1 can refer to the kit of the present invention.
- the fourth composition can be mixed with water to form an aqueous solution of the fourth composition.
- an aqueous solution is substantially corresponding to the second composition of the kit according to the present invention.
- the aqueous solution is mixed with the first composition, e.g., referring to the way for mixing the first composition and the second composition of the kit according to the present invention.
- the mask package 1 comprises:
- a nonwoven fabric comprising from 0.01%to 5%by weight, preferably from 0.02%to 1%by weight, or preferably from 0.04%to 0.5%, of calcium sulphate or calcium carbonate, and from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, of HEC or HPC, relative to the total weight of the nonwoven fabric, and
- a fourth composition which is free of water, comprising from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, of the water soluble chelating agent and from 0.1%to 0.5%by weight, preferably from 0.2%to 0.4%by weight, of the water soluble gelatinizing agent, relative to the total weight of the composition,
- weight ratio of the nonwoven fabric to the fourth composition ranges from 1: 3 to 1: 20, preferably from 1: 8 to 1: 15.
- the first composition and the second/fourth composition according to the present invention can be generally prepared according to the general knowledge of a person skilled in the art. Nevertheless, it is to be understood that a person skilled in the art can choose the method of preparation, on the basis of his/her general knowledge, taking into account the nature of the constituents used, for example, their solubility in the vehicle, and the application envisaged for the compositions or the kit.
- the kit according to the present invention can be used for caring for keratin materials, especially the face.
- This use may manifest itself as a process for caring for keratin materials, especially the face, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to said keratin materials the thus obtained mixture as a mask.
- the kit according to the present invention can be used for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, and so on.
- This use may manifest itself as a process for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to a location in need of the thus obtained mixture as a mask or stuffing.
- compositions/formulas described below are expressed in %by weight, relative to the total weight of each composition/formula.
- the invention formulas A and B, and comparative formula A were prepared, as the second composition.
- Protocol of preparation of the second composition using the formulas in table 1 all the ingredients were put into beaker, heated to 60°C and homogenized until uniform, cooled down to room temperature.
- Protocol of preparation of masks 0.75g of each of the formulas A to B and comparative A, respectively, were placed together with a nonwoven fabric with a weight of 1.3g, made of 20%by weight of calcium alginate fiber and 80%of lyocell fiber, sold by the Sanjiang company under the name M762R-40CN.
- the present invention and comparative masks were evaluated using the following protocols.
- Evaluation process Apply the mask on face for 15 minutes and then take off and massage the skin. Perceive the greasiness of skin by moving finger pulp on the face. Then each panelist gave the score from 0 to 15. The less greasiness, the high score was given.
- Evaluation index We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
- Evaluation process Apply the mask on face, and observe the quantity of bubbles around eye, nose and mouth. Then each panelist gave the score from 0 to 15. The less bubbles, the high score was given.
- Evaluation index We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
- Evaluation process Apply the mask on face for 15 minutes and then take off and massage the skin. Observe the degree of lines on forehead and nasolabial folds, touch the cheek by index finger and middle figer and perceive the skin softness by tactile way, and observe the degree of fine lines on the cheek. Each panelist gave the score from 0 to 15. The more plumpy skin, the high score was given.
- Evaluation Index We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
- Evaluation process Apply the mask on face for 15 minutes and then take off. Observe the quantity of juice left on skin by visual way. Then each panelist gave the score from 0 to 15. The more juice left on skin, the higher score was given.
- Evaluation index We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
- Formula A Formula B Comparative Formula A Texture transformation Good Excellent poor Skin adhesion Excellent Excellent fair Fresh feel Excellent Fair good Hydration effect good Excellent fair Moisture delivery capacity excellent Fair poor
- the mask of the present invention is superior in terms of beneficial properties, e.g. texture transformation, hydration effect and moisture delivery capacity, over the comparative one.
- the invention formula C, and comparative formulas B-D were prepared, as the first composition.
- Protocol of preparation of masks 0.75g of formula A was placed together with a nonwoven fabric with a weight of 1.3g, made of formula C and comparative formulas B-D, respectively, so as to provide mask C, and comparative masks B-D, respectively.
- the present invention and comparative masks were evaluated using the following protocols.
- Deformation (%) ( (value measured after fresh mix) - (initial value) ) / (initial value) .
- the mask of the present invention is superior in terms of softness, over the comparative one.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
A kit comprises: (1) a first composition comprising at least one water insoluble salt of polyvalent metal and at least one water soluble polyhydroxy polymer, and (2) a second composition comprising at least one aqueous phase, and a) optionally, at least one water soluble chelating agent of the polyvalent metal ion, and b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion. The kit can be used for caring for keratin materials, in particular the skin, for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects.
Description
The present invention relates to an alginic system, especially to an alginic kit caring for the skin. Further, the present invention relates to use of same, especially as a mask for caring for keratin materials, especially the skin.
BACKGROUND ART
It has always been an ultimate goal of the cosmetic filed to deliver to the consumers’highly efficient products with skin benefits such as hydration, moisturizing, whitening, cleansing, and so on.
Among all the compositions for caring for keratin materials, in particular the skin, masks are known to have high penetration efficacy on the keratin materials. As a result, a two-digit market growth of mask cosmetic products in China was seen.
In general, there are four types of masks, i.e., paste type, peel-off type, gel type, and wet tissue type masks. Among others, paste type and peel-off type masks are mainly used for cleansing of the keratin materials, whereas gel type and wet tissue type masks are more often used for caring for the skin. It is known that, a gel type mask having good adhesion to the skin and can provide good fresh feel, however, may be insufficient in delivering moisturizing or hydration effect to the skin, while a wet issue type mask is good at delivering moisturizing and hydration effect, but will take it back if applied for an elongated period of time. Besides, the adhesion with the skin may not be as good as the gel type masks.
Meanwhile, for masks, in particular tissue type masks, it is desired that the mask to be applied on face is soft, bringing better touch feeling and better fitness to the skin.
Based on the foregoing, there is a need for a new type of mask, which integrates two or more of the merits exhibited by the known mask types, but does not suffer from one or more problem (s) associated therewith.
AIMS OF INVENTION
Therefore, in one aspect, it is necessary to provide masks, which is capable of texture transformation, for example, from tissue to gel, creating a pleasant consumer experience.
In another aspect, it is necessary to provide masks, which have a moisture or actives delivery capacity that is at least on par with or even greater than that observed with wet tissue type masks.
In another aspect, it is necessary to provide masks, which have good adhesion with the skin, and can provide fresh feeling, just like gel type masks.
In another aspect, it is necessary to provide masks, which can deliver moisturizing effect or actives to keratin materials for an elongated period of time and does not take it back, whereby exhibiting further improved e.g. hydration effect as compared with wet tissue type masks.
In another aspect, it is necessary to provide masks, which are significantly effective in fine line improvement.
In another aspect, it is necessary to provide masks, which integrate all of the benefits described in the preceding aspects.
In another aspect, the present inventors discovered that the conception or gist of the present invention is applicable not only to the cosmetic field, but also to other fields like the medical field, then the masks of the preceding aspects may be broadened to kits, which show the benefits described herein in connection with these masks as well.
DISCLOSURE OF INVENTION
The present inventors have discovered that a specific combination of 1) a first composition comprising at least one water insoluble salt of polyvalent metal, as an ion donator of the polyvalent metal, and at least one water soluble polyhydroxy polymer; and 2) a second composition comprising at least one aqueous phase, and a) optionally, at least one water soluble chelating agent of the polyvalent metal ion, and b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion may satisfy one or more of the abovementioned requirements.
One subject of the invention is thus to provide a kit comprising the first composition and the second composition separately placed from one another.
Another subject of the present invention is a mask package 1, comprising: 1) a first composition comprising at least one water insoluble salt of polyvalent metal, at least one fiber rich in hydroxy groups, and at least one water soluble polyhydroxy polymer, and 2) a fourth composition comprising at least one aqueous phase, and, b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion; wherein the first composition and the fourth composition are separately placed from one another.
Another subject of the present invention is use of the second composition as juice or a part of juice for mask product, wherein the mask product comprises, separate from the second composition, a fabric (or tissue) comprising at least one water insoluble salt of polyvalent metal according to the invention.
Another subject of the present invention is use of the kit according to the present invention for caring for keratin materials, especially the skin. This use may manifest itself as a process for caring for keratin materials, especially the skin, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to said keratin materials the thus obtained mixture.
Another subject of the present invention is use of the kit according to the present invention for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, and so on. This use may manifest itself as a process for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to a location in need of the thus obtained mixture.
Other characteristics and advantages of the present invention will emerge more clearly on reading the description and the examples that follow.
DETAILED DESCRIPTION OF INVENTION
Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of components and/or reaction conditions are to be understood as being modified in all instances by the term "about, " meaning within 10%of the indicated number (e.g. "about 10%" means 9%-11%and "about 2%" means 1.8%-2.2%) .
The articles "a" and "an, " as used herein, mean one or more when applied to any feature in embodiments of the present invention described in the specification and claims. The use of "a" and "an" does not limit the meaning to a single feature unless such a limit is specifically stated. The article "the" preceding singular or plural nouns or noun phrases denotes a particular specified feature or particular specified features and may have a singular or plural connotation depending upon the context in which it is used. The adjective "any" means one, some, or all indiscriminately of whatever quantity.
The term "comprising" (and its grammatical variations) as used herein is used in the inclusive sense of "having" or "including" and not in the exclusive sense of "consisting only of. " Nonetheless, those skilled can realize without any doubt for an embodiment capable of being carried out in the form of "comprising" , the forms of "consisting essentially of" and "consisting of" are naturally modifications of the embodiment, and are also within the scope of the invention.
All percentages and ratios are calculated by weight unless otherwise indicated. All percentages are calculated based on the total weight of a composition unless otherwise indicated. All component or composition levels are in reference to the active level of that component or composition, and are exclusive of impurities, for example, residual solvents or by-products, which may be present in commercially available sources.
Preferably, the “keratin material” according to the present invention is the skin. By “skin” , we intend all the body skin. Still preferably, the keratin material is the face, or the neck, especially the face.
By “topical application” , it meant that the composition is applied or spread onto the surface of the keratin materials, such as at least one zone of the skin.
By "rinse off" , it is meant a composition which after being applied on the skin for a predetermined period of time, is removed from the skin by a rinsing composition such as water.
By “alkali metal” , it refers to an element located in Group IA of the periodic table, such as sodium, potassium, lithium or a combination thereof, preferably sodium, potassium or a combination thereof.
The term "water-soluble or water-dispersible" means a compound which, when introduced into water at 25℃, at a mass concentration equal to 1%, make it possible to obtain a macroscopically homogeneous and transparent solution, i.e. a solution with a maximum light transmittance value, at a wavelength equal to 500 nm, through a sample 1 cm thick, of at least 60%and preferably of at least 70%.
In the application, unless specifically mentioned otherwise, contents, parts and percentages are expressed on a weight basis.
According to the present invention, the kit comprises a first composition and a second composition.
First composition
First of all, the first composition according to the present invention comprises at least one water insoluble salt of polyvalent metal and at least one water soluble polyhydroxy polymer.
Water insoluble salt of polyvalent metal
The term “water insoluble” means that the salt is not dissolvable, e.g., having a solubility of less than 0.01g/100g of water or only slightly soluble, e.g., having a solubility of less than 0.5g/100g of water, in water, nor does it break apart in the bulk state upon immersion in water.
In particular, the at least one water insoluble salt of polyvalent metal may be present in form of powder, particulate, fiber or bulk state.
For the purposes of the present invention, the term "particulate" , when being used for the water insoluble salt of polyvalent metal, means that the salt is in the form of particles.
Specifically, water insoluble salt of polyvalent metal may be formed from an acid anion and a polyvalent metal cation, especially calcium, strontium, zinc, copper, manganese, aluminum, or mixtures thereof. The useful metal is preferably calcium, copper or a mixture thereof, more preferably calcium.
The acid to provide acid anion according to the present invention can be any known acid useful in cosmetic products, provided that the salt formed from the acid with the polyvalent metal is water insoluble or slightly soluble. The typical acids may be used comprise various inorganic acids, e.g., sulphate, carbonic acid, phosphoric acid meta-aluminic acid, silicic acid, and various organic acids, especially higher saturated or unsaturated fatty acids, in particular those having 18 or more carbon atoms, e.g., stearic acid and oleic acid, or polycarboxylic acids, especially e.g., alginic acid, oxalic acid, as long as the salt formed is water insoluble or slightly soluble.
More specifically, the at least one water insoluble salt of polyvalent metal may be a sulphate or alginate, preferably chosen from calcium sulphate/alginate, strontium sulphate/alginate, zinc sulphate/alginate, copper sulphate/alginate, manganese sulphate/alginate, or a mixture thereof, preferably calcium sulphate/alginate or copper sulphate/alginate, in particular calcium sulphate/alginate.
The term "alginate" in particular means a salt of alginic acid. Alginic acid, a natural substance obtained from brown algae or from certain bacteria, is a polyuronic acid composed of two uronic acids linked together via 1, 4-glycoside bonds: β-D-mannuronic acid (M) and α-L-glucuronic acid (G) .
Water insoluble alginates, in which the principal cation is calcium, are specifically found in the fronds and stems of seaweeds of the class Phaeophyceae, examples of which are Fucus vesiculosus, Fucus spiralis, Ascophyllum nodosum, Macrocystis pyrifera, Alaria esculenta, Eclonia maxima, Lessonia nigrescens, Lessonia trabeculata, Laminaria japonica, Durvillea antarctica, Laminaria hyperborea, Laminaria longicruris, Laminaria digitata, Laminaria saccharina, Laminaria cloustoni, and Saragassum sp.
Suitable water insoluble alginates have a weight-average molecular weight of about 20,000 Daltons to about 500,000 Daltons. The weight-average molecular weight is calculated by first determining the intrinsic viscosity, then using the Mark-Houwink Sakurada Equation, as in Martinsen, et al, "Comparison of Different Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates" (Carbohydr. Polym., 15, 171-193, 1991) .
Water soluble polyhydroxy polymer
The term "polyhydroxy polymer" means a hydroxy-containing nonionic polysaccharide.
The inventors have surprisingly discovered that a polymer rich in hydroxy groups can soften fibers, in particular when the fiber is also rich in hydroxy groups. Here, fiber rich in hydroxy groups means a fiber having at least 2 hydroxy groups, preferably at least 3 hydroxy groups, per repeating unit of the polymer of the fiber and having at least one hydroxy-containing side chain, wherein less than 60%, preferably less than 30%, or preferably less than 15%, of hydroxy groups in the side chains are substituted.
Useful water soluble polyhydroxy polymers comprise polyhydroxycarboxylic acids, esters of the acids; polyhydroxy celluloses; and the like.
Some celluloses are known to be useful for promoting gelling behavior. Accordingly, polyhydroxy celluloses are preferably useful.
In particular, nonionic polyhydroxy cellulose ethers are specially preferable, in which mention may be made of hydroxyalkylcelluloses such as hydroxymethylcelluloses, hydroxyethylcelluloses (HEC) and hydroxypropylcelluloses (HPC) ; and mixed hydroxyalkylalkylcelluloses such as hydroxy propylmethylcelluloses, hydroxy ethylmethylcelluloses, hydroxy ethylethylcelluloses and hydroxybutylmethylcelluloses.
According to an embodiment, the first composition of the present invention may comprise the at least one water soluble polyhydroxy polymer in a content ranging from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, relative to the total weight of the first composition.
Superabsorbent material
According to an embodiment of the present invention, the first composition may comprise at least one superabsorbent material.
In particular, the at least one superabsorbent material may be present in form of powder, particulate, fiber or bulk state.
The superabsorbent material advantageously presents very great ability to absorb a liquid, and in particular water. In particular, it may present the capacity to absorb 15 times, or even 20 times to 50 times its own weight in water, e.g. about 25 times to 30 times.
The capacity of the superabsorbent material for absorbing liquid can be determined by implementing the following method.
A sample of the superabsorbent material in the powder, fiber, or bulk state, or arranged as a film or a sheet, is weighed while in the dry state (M
D) . For example it is possible to use a non-woven square web having a side of about 1 centimeter (cm) . In the context of the present method, the superabs orbent material is obtained in the "dry" state by being treated in a drying oven for about 4 hours (h) at about 50℃.
Water (or any other liquid that is to be absorbed by the material) is put into contact with the material. This can be done either by immersing the material in the liquid, or else by pouring the liquid onto the material. For example, the material may be immersed for a duration of about 1 minute (min) .
The quantity of water (or liquid) is used in excess so as to saturate the material completely, for example. The excess water (or liquid) is then eliminated, e.g. by drip-drying for about 2 min, and the material saturated in liquid is weighed (M
L) .
The difference Δ between the weight of the material when saturated in liquid and the weight of the material when dry represents the quantity of liquid that it has absorbed, which weight is compared with the dry weight of the material. The resulting value C is indicative of the capacity of the superabsorbent material to absorb the liquid, e.g. expressed in grams of liquid absorbed per gram of dry material:
The superabsorbent material may be selected from cellulose derivatives, alginates (not including the water insoluble alginates and the alkali metal alginic compounds described herein as the water soluble gelatinizing agent) and derivatives thereof, in particular derivatives such as propylene glycol alginate, or salts thereof, derivatives of polyacrylic acid or polymethacrylic acid, derivatives of poly (meth) acrylamide, derivatives of polyvinylpyrrolidone, derivatives of poly-vinyl ether, and mixtures thereof, amongst others.
In particular, the superabsorbent material may be selected from derivatives of chemically modified cellulose. For example it may be selected from carboxy-methyl cellulose, sodium carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, carboxyethyl cellulose, hydroxyethylethyl cellulose, hydroxypropylmethyl cellulose, methyl cellulose, sodium methyl cellulose, microcrystalline cellulose, sodium cellulose sulfate, and mixtures thereof.
It may also be selected from alkyl celluloses. These polymers are obtained by grafting an alkyl residue onto one or more hydroxy groups of the cellulose polymer to form the hydroxyalkyl derivative. These alkyl residues may be selected from the following groups: stearyl, isostearyl, lauryl, myristyl, cetyl, isocetyl, cocoyl, palmityl, oleyl, linonyl, ricinolyl, behenyl, and mixtures thereof. These hydroxyalkyl cellulose derivatives may also be subjected to chemical modification, e.g. using a carboxylic residue.
The superabsorbent material may also be selected from natural polymer derivatives, such as, for example, gellan gum and glucomannan and galactomannan polysaccharides extracted from seeds, vegetable fibers, fruit, seaweed, starch, plant resins, or indeed of microbial origin. For example, it may be selected from agar gum, guar gum, gum tragacanth, carrageenan gum, konjac gum, locust bean gum, gellan gum, xanthan gum, and mixtures thereof.
In particular, the first composition of the present invention may comprise the at least one superabsorbent material in a content ranging from 0%to 80%by weight, especially from 50%to 80%by weight, or even the rest, relative to the total weight of the first composition.
According to an embodiment of the present invention, in particular for mask use, the first composition further comprises additional fibers other than one formed from the at least one water insoluble salt of polyvalent metal, where the at least one water insoluble salt of polyvalent metal and the at least one water soluble polyhydroxy polymer are loaded to the additional fibers.
For example, according to an embodiment 1, the water insoluble salt of polyvalent metal may be present in form of fiber. Then, the fiber of the at least one water insoluble salt of polyvalent metal may, solely or together with one or more other fibers, be formed into a water insoluble substrate. The water soluble polyhydroxy polymer is loaded to the substrate.
Or alternatively, according to an embodiment 2, the water insoluble salt of polyvalent metal, as well as the water soluble polyhydroxy polymer, may be each distributed uniformly in a water insoluble substrate.
Water insoluble substrate
For the purpose of the present invention, the term “water insoluble” means that the substrate is not dissolvable in water, nor does it break apart upon immersion in water.
Embodiment 1:
Typically, in this embodiment 1, the substrate may be a woven or nonwoven fabric made of a fiber of the at least one water insoluble salt of polyvalent metal (also referred to as water insoluble polyvalent metal salt fiber hereinafter) together with at least one other fiber chosen from natural fibers such as cotton, pulp, bamboo and cellulose fibers, semi-natural fibers such as viscose rayon fibers, synthetic fibers such as polyester fibers, polyethylene terephthalate fibers, polyethylene fibers and polypropylene fibers. Two or more selected from the other fibers may be used in combination.
The inventors have discovered surprisingly that fibers rich in hydroxy groups can be readily softened with a water soluble polyhydroxy polymer. Accordingly, fibers rich in hydroxy groups are preferably used according to the present invention. Such fibers can be regenerated cellulose or cotton fiber. Examples of fibers rich in hydroxy groups comprise Viscose, Modal, Lyocell, Cupro, Cotton and the like.
The substrate can be made into a wide variety of shapes and forms such as flat pads, thick pads, thin sheets of irregular thickness, depending on the desired use and characteristic of the kit. Just for example, the substrate is typically designed to fit the area of the skin in the case of mask to which topical application is desired. To this end, when the mask is applied to the face, the substrate is designed to correspond to the shape of the face avoiding the eye, nostril, and mouth areas, as necessary. Non-limiting examples of the substrates useful in the present invention are described, for example, in the patent application WO 02/062132, or EP 2489286A.
According to the embodiment 1, the water insoluble polyvalent metal salt is preferably formed from an organic acid, especially higher saturated or unsaturated fatty acids, in particular those having 18 or more carbon atoms, e.g., stearic acid and oleic acid, or polycarboxylic acids, especially e.g., alginic acid, oxalic acid.
In particular, the water insoluble substrate or the fabric may comprise the water insoluble polyvalent metal salt fiber, especially calcium alginate fiber, in an amount ranging from 10%to 80%by weight, especially from 10%to 40%by weight, relative to the total weight of the water insoluble substrate or the fabric. Correspondingly, the water insoluble substrate or the fabric may comprise the at least one other fiber in an amount ranging from 10%to 80%by weight, especially from 50%to 80%by weight, relative to the total weight of the water insoluble substrate or the fabric.
More particularly, a suitable nonwoven fabric comprising calcium alginate fiber is commercially available from the Sanjiang company under the name M762R-40CN.
Embodiment 2:
Alternatively, according to an embodiment 2, the substrate may comprise a woven or nonwoven fabric consisting essentially of at least one fiber chosen from natural fibers such as cotton, pulp, bamboo and cellulose fibers, semi-natural fibers such as viscose rayon fibers, synthetic fibers such as polyester fibers, polyethylene terephthalate fibers, polyethylene fibers and polypropylene fibers. For such a substrate, the at least one water insoluble salt of polyvalent metal is distributed as uniformly as possible in the substrate.
Accordingly, the water insoluble salt of polyvalent metal is prepared into an aqueous dispersion, e.g., for water insoluble salt of calcium. Then, the dispersion is applied, e.g., through coating, spraying and the like, onto the substrate, so as to distribute uniformly the salt of calcium in the substrate in an amount sufficient to form a gel on the substrate with alginate. The wet substrate loaded with the aqueous salt is subsequently dried. The method to dry the tissue is not limited specifically. For industrial application, the wet substrate is dried in an economically effective manner.
According to another embodiment, water insoluble salt of polyvalent metal, such as the salt of calcium, e.g., as water insoluble salt, in solid form is crushed into powder or particles, e.g., through milling, grinding and the like. Then, the powder or particle is applied uniformly onto the substrate. The diameter of the powder or particle is not limited specifically, as long as the water insoluble salt of polyvalent metal can be distributed uniformly in the substrate in an amount sufficient to form a gel on the substrate with alginate.
According to the embodiment 2, the water insoluble polyvalent metal salt is preferably formed from an inorganic acid, e.g., one selected from the group consisting of sulfonic acid, carbonic acid, phosphoric acid meta-aluminic acid, silicic acid, preferably sulfonic acid.
According to embodiment 2, the water insoluble substrate or the fabric may comprise the water insoluble polyvalent metal salt, especially calcium salt, in an amount ranging from 0.01%to 5%by weight, preferably from 0.02%to 1%by weight, or preferably from 0.04%to 0.5%by weight, relative to the total weight of the water insoluble substrate or the fabric.
Process to combine the polyhydroxy polymer with the substrate
In order to provide a softened substrate, the water soluble polyhydroxy polymer is preferably combined with the water insoluble substrate. The process to combine the water soluble polyhydroxy polymer with the water insoluble substrate is not limited specifically, as long as the water soluble polyhydroxy polymer can be distributed uniformly in the substrate in an amount sufficient to soften the substrate to the desirable extent.
According to an embodiment, the water soluble polyhydroxy polymer is prepared into an aqueous solution. Then, the water soluble polyhydroxy polymer is loaded onto the substrate, e.g., a mask tissue.
According to another embodiment, the water soluble polyhydroxy polymer is prepared into a suspension or paste, e.g., a water soluble water soluble polyhydroxy polymer suspended in or mixed with a medium other than water to form a suspension or paste thereof. Then, the suspension or paste is applied, e.g., through coating, spraying and the like, onto the substrate, so as to distribute uniformly the water soluble polyhydroxy polymer in the substrate in an amount sufficient to form a gel on the substrate with alginate.
For the cases using an aqueous solution, a suspension or a paste to apply the water soluble polyhydroxy polymer, the wet substrate loaded with the aqueous salt is subsequently dried. The method to dry the tissue is not limited specifically. For industrial application, the wet substrate is dried in an economically effective manner.
According to still another embodiment, the water soluble polyhydroxy polymer in solid form is crushed into powder or particles, e.g., through milling, grinding and the like. Then, the powder or particle is applied uniformly onto the substrate. The diameter of the powder or particle is not limited specifically, as long as the water soluble polyhydroxy polymer can be distributed uniformly in the substrate in an amount sufficient to soften the substrate.
According to the invention, the water insoluble substrate or the fabric may comprise the water soluble polyhydroxy polymer, e.g., HEC or HPC, in an amount ranging from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, relative to the total weight of the, relative to the total weight of the water insoluble substrate or the fabric.
The kit according to the present invention comprises, separate from and isolated with the first composition (e.g. the water insoluble substrate) , a second composition. The second composition, as needed, impregnates, coats or is otherwise in contact with the first composition, so as to transform the texture of the first composition, for example, from tissue to gel.
Preferably, for a sufficient texture transformation, the weight ratio of the first composition (e.g. the water insoluble substrate or the fabric) to the second composition ranges from 1: 3 to 1: 20, preferably from 1: 8 to 1: 15.
Second Composition
The second composition of the present invention at least comprises a) optionally, at least one water soluble chelating agent of the polyvalent metal ion and b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion.
According to the present invention, when the first composition is mixed with the second composition, the water insoluble polyvalent metal ion donator reacts with salt in solution and releases the polyvalent metal ions. When the second composition does not comprise component a) , i.e., the at least one water soluble chelating agent of the polyvalent metal ion, the polyvalent metal ions released into solution react with component b) , i.e., the at least one water soluble gelatinizing agent, directly. When the second composition comprises component a) , most of the polyvalent metal ions released into solution would be trapped by the water soluble chelating agent. A few of free polyvalent metal ions in the solution react with the water soluble gelatinizing agent and start to gelatinize on the tissue surface. As the concentration of free polyvalent metal ions decreases over time, the chelated polyvalent metal ions would be gradually released and then gelatinize on the tissue surface. After a short period of time, transformation of tissue texture and a homogeneous gel on the tissue surface would be observed.
Chelating agent of the polyvalent metal ion
The second composition according to the present invention comprises optionally component a) , i.e., at least one water soluble chelating agent of the polyvalent metal ion, to facilitate the texture transformation, and specially, to boost at least the moisture or actives delivery capacity. The water soluble chelating agent of the polyvalent metal ion is water-soluble.
According to the present invention, when the first composition is mixed with the second composition comprising component a) , the water insoluble polyvalent metal ion donator releases few or more of the polyvalent metal ions into solution. Both the chelating agent of the polyvalent metal ion and the water soluble gelatinizing agent are capable of being combined with the polyvalent metal ions.
Surprisingly, the specific chelating agent according to the present invention conquers the gelatinizing agent in the competition of combination with the polyvalent metal ion, such that most of polyvalent metal ions released are trapped by the water soluble chelating agent. There are still a few of free polyvalent metal ions in the solution to react with the water soluble gelatinizing agent and start to gelatinize on the tissue surface. As the concentration of free polyvalent metal ions decreases over time, the chelated polyvalent metal ions would be gradually released and then gelatinize on the tissue surface. That is, the specific chelating agent according to the present invention serves as a reservoir of the polyvalent metal ions for the gelatinization on the tissue surface.
According to the present invention, the useful chelating agent of the polyvalent metal ion comprises aminocarboxylic acids, e.g., elhylenediamine tetraacetic acid (EDTA) , aminotriacetic acid, diethylene triaminepentaacetic acid, and in particular the alkali metal salt thereof, e.g., N, N-bis (carboxymethyl) glutamic acid, tetrasodium EDTA, tetrasodium salt of N, N-bis (carboxymethyl) glutamic acid (glutamic acid diacetic acid, GLDA) ; hydroxy carboxylic acids, e.g., citric acid, tartaric acid, glucuronic acid, succinic acid, ethylenediamine disuccinic acid (EDDS) , and in particular the alkali metal salt thereof; hydroxy aminocarboxylic acids, e.g., hydroxyethylethylenediamine triacetic acid (HEDTA) , dihydroxyethylglycine (DEG) , and in particular the alkali metal salt thereof; polyphosphonic acid, and in particular the alkali metal salt thereof; other phosphor-containing organic acid, e.g., phytic acid, and in particular the alkali metal salt thereof, e.g., sodium phytate, potassium phytate polycarboxylic acid, e.g., polyacrylic acid, polymethacrylic acid, and in particular the alkali metal salt thereof.
In one embodiment, the at least one water soluble chelating agent of the polyvalent metal ion is an alkali metal hydroxy polycarboxylate represented by an alkane containing from 1 to 4 carbon atoms, preferably containing 2 or 3 carbon atoms, substituted by 1, 2, or 3 hydroxy groups (-OH) , preferably by one (1) hydroxy group, and further substituted by 2, 3, 4 or 5 carboxylate groups (-COOM) , preferably by 2 or 3 carboxylate groups (-COOM) , wherein the multiple groups M independently represent H or alkali metal, with the proviso that at least one of the groups M represents alkali metal, such as Na, K or Li, preferably all groups M represent alkali metal, such as Na, K or Li, preferably Na. More specifically, the at least one alkali metal hydroxy polycarboxylate may be chosen from sodium tartrates, sodium citrates, potassium tartrates, potassium citrates, and hydrates thereof, preferably sodium citrates, in particularly trisodium citrate. Herein, sodium citrates are used to indicate monosodium citrate, disodium citrate and trisodium citrate, and other alkali metal hydroxy polycarboxylates may be understood in a similar way.
Amongst others, the alkali metal mentioned above is preferably sodium or potassium, in particular sodium. Accordingly, preferable chelating agents can comprise sodium citrate, tetrasodium EDTA, tetrasodium GLDA, trisodium EDDS, sodium phytate, or a mixture thereof.
In particular, the second composition of the present invention may comprise the at least one water soluble chelating agent of the polyvalent metal ion in a content ranging from 0.1%to 1%by weight, especially from 0.2%to 0.4%by weight, relative to the total weight of the second composition.
Water soluble gelatinizing agent
The second composition according to the present invention comprises at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion, to trigger the texture transformation.
In this application, the term "water soluble gelatinizing agent" specifically means one gelatinizable with the polyvalent metal ion from the first composition.
According to the present invention, when the first composition is mixed with the second composition, the water insoluble polyvalent metal ion donator releases few or more of the polyvalent metal ions into solution.
According to principle of the present invention, the gelatinizing agent can thus be anyone gelatinizable with the polyvalent metal ion. Examples of the gelatinizing agent can comprise glutins, pectins, gellan gum, carrageenans, agars, alginic compounds and in particular alkali metal salts of alginic acid, e.g., sodium alginate, and mixtures thereof. When the second composition comprises component a) , i.e., the chelating agent, the gelatinizing agent and the chelating agent are both specifically selected where the gelatinizing agent has an ability of combining with the polyvalent metal ions lower than that of the chelating agent, such that the gelatinizing agent does not combine the free polyvalent metal ions released directly from the first composition, but combines with the polyvalent metal ions subsequently from the reservoir, i.e., the chelated polyvalent metal ions. Accordingly, a gel on the surface of the first composition can be formed.
Pectins are linear polymers of α-D-galacturonic acid (at least 65%) linked in positions 1 and 4 with a certain proportion of carboxylic groups esterified with a methanol group. About 20%of the sugars constituting the pectin molecule are neutral sugars (L-rhamnose, D-glucose, D-galactose, L-arabinose, D-xylose) . L-Rhamnose residues are found in all pectins, incorporated into the main chain in positions 1, 2.
Uronic acid molecules bear carboxyl functions. This function gives pectins the capacity for exchanging ions, when they are in COO
- form. Divalent ions (in particular calcium) have the capacity of forming ionic bridges between two carboxyl groups of two different pectin molecules.
In the natural state, a certain proportion of the carboxylic groups are esterified with a methanol group. The natural degree of esterification of a pectin may range between 70%(apple, lemon) and 10% (strawberry) depending on the source used. Using pectins with a high degree of esterification it is possible to hydrolyse the-COOCH
3 groups, so as to obtain weakly esterified pectins. Depending on the proportion of methylated or non-methylated monomers, the chain is thus more or less acidic. HM (high-methoxy) pectins are thus defined as having a degree of esterification of greater than 50%, and LM (low-methoxy) pectins are defined as having a degree of esterification of less than 50%.
In the case of amidated pectins, the-OCH
3 group is substituted with a -NH
2 group.
Pectins are especially sold by the company Cargill under the name Unipectine
TM, by the company CP-Kelco under the name Genu, and by Danisco under the name Grinsted Pectin.
Carrageenans are anionic polysaccharides constituting the cell walls of various red algae (Rhodophyceae) belonging to the Gigartinacae, Hypneaceae, Furcellariaceae and Polyideaceae families. They are generally obtained by hot aqueous extraction from natural strains of said algae. These linear polymers, formed by disaccharide units, are composed of two D-galactopyranose units linked alternately by α (1, 3) and β (1, 4) bonds. They are highly sulfated polysaccharides (20-50%) and the α-D-galactopyranosyl residues may be in 3, 6-anhydro form. Depending on the number and position of sulfate-ester groups on the repeating disaccharide of the molecule, several types of carrageenans are distinguished, namely: kappa-carrageenans, which bear one sulfate-ester group, iota-carrageenans, which bear two sulfate-ester groups, and lambda-carrageenans, which bear three sulfate-ester groups.
Carrageenans are composed essentially of potassium, sodium, magnesium, triethanolamine and/or calcium salts of polysaccharide sulfate esters.
Carrageenans are sold especially by the company SEPPIC under the name
by the company Gelymar under the names
and
by the company Cargill, under the names Satiagel
TM and Satiagum
TM, and by the company CP-Kelco under the names
and
Agars are galactose polysaccharides contained in the cell wall of some of these species of red algae (rhodophyceae) . They are formed from a polymer group whose base backbone is a β (1, 3) D-galactopyranose and α (1, 4) L 3-6 anhydrogalactose chain, these units repeating regularly and alternately. The differences within the agar family are due to the presence or absence of solvated methyl or carboxyethyl groups. These hybrid structures are generally present in variable percentage, depending on the species of algae and the harvest season.
Agar-agar is a mixture of polysaccharides (agarose and agaropectin) of high molecular mass, between 40000 and 300000 g. mol
-1. It is obtained by manufacturing algal extraction liquors, generally by autoclaving, and by treating these liquors which comprise about 2%of agar-agar, so as to extract the latter.
Agar is produced, for example, by the group B&V Agar Producers under the names Gold Agar, Agarite and Grand Agar by the company Hispanagar, and under the names Agar-Agar, QSA (Quick Soluble Agar) , and Puragar by the company Setexam.
Gellan gum is an anionic linear heteropolyoside based on oligoside units composed of 4 saccharides (tetra-oside) . D-Glucose, L-rhamnose and D-glucuronic acid in 2: 1: 1 proportions are present in gellan gum in the form of monomer elements.
It is sold, for example, under the name Kelcogel CG LA by the company CP Kelco.
In one embodiment of the present invention, the gelatinizing agent is preferably chosen from alkali metal alginic compounds. The particularly preferable gelatinizing agent is alginate, e.g., sodium or potassium alginate, especially sodium alginate.
According to an embodiment, the at least one water soluble gelatinizing agent is present in the second composition from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, relative to the total weight of the second composition.
According to the present invention, the amounts of the chelating agent and the gelatinizing agent are so selected that the molar ratio of the moiety to be released from the chelating agent chelatable with the polyvalent cation to the moiety to be released from the gelatinizing agent gelatinizable with the polyvalent cation ranging from about 10: 1 to about 1: 1, preferably from about 5: 1 to about 2: 1.
Alkali metal alginic compound
The term "alkali metal alginic compound" in particular means alkali metal alginic acid salts (alginates) or alkali metal salts of alginic acid derivatives. The alkali metal alginic compound is water-soluble.
Alginic acid, a natural substance obtained from brown algae or from certain bacteria, is a polyuronic acid composed of two uronic acids linked together via 1, 4-glycoside bonds: β-D-mannuronic acid (M) and α-L-glucuronic acid (G) .
Alginic acid is capable of forming water-soluble salts (alginates) with alkali metals such as sodium, potassium or lithium. These alginates are water-soluble in aqueous medium at pH 4 but dissociate into alginic acid at a pH below 4.
Methods for the recovery of these water-soluble salts, especially sodium alginate, from natural sources are well known, and are described, for example, in Green, U.S. Pat. No. 2,036,934, and Le Gloahec, U.S. Pat. No. 2,128,551.
Alginic acid or alginates may be chemically modified, especially with urea or urethane groups or by hydrolysis, oxidation, esterification, etherification, sulfatation, phosphatation, amination, amidation or alkylation reaction, or by several of these modifications, forming alginic acid derivatives, including salts.
These derivatives may be anionic, cationic, amphoteric or nonionic, and are capable of forming water-soluble salts with an alkali metal such as sodium, potassium or lithium, forming alkali metal salts of alginic acid derivatives.
More specifically, alginates may be reacted with an alkylene oxide, such as ethylene oxide or propylene oxide, to form polyglycol alginates. The polyglycol segment is bonded to alginates through the carboxyl group (s) . Typically, alginates react with propylene oxide to form polypropylene glycol alginates (PPG alginates) , while react with ethylene oxide to form polyethylene glycol alginates (PEG alginates) . Preparation of polyglycol alginates is disclosed in Strong, U.S. Pat. No. 3,948,881, Pettitt, U.S. Pat. No. 3,772,266, and Steiner, U.S. Pat. No. 2,426,125.
Preferably, the polyglycol alginate has a degree of esterification of about 40%to about 95%, more preferably about 70%to 95%.
Suitable alginates have a weight-average molecular weight of about 20,000 Daltons to about 500,000 Daltons. The weight-average molecular weight is calculated by first determining the intrinsic viscosity, then using the Mark-Houwink Sakurada Equation, as in Martinsen, et al, "Comparison of Different Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates" (Carbohydr. Polym., 15, 171-193, 1991) .
The weight-average molecular weights indicated above are also valid for the alkali metal salts of alginic acid derivatives.
A list of various commercially available alginates, their properties, and their sources is found in Shapiro, U.S. Pat. No. 6,334,968, Table 1, column 16, line 49, to column 17, line 18, incorporated herein by reference.
According to an embodiment of the present invention, the alkali metal alginic compound may be chosen from sodium alginate and potassium alginate, preferably sodium alginate.
The alkali metal alginic compounds that are suitable for use in the present invention may be represented, for example, by the products sold under the names Kelcosol, Satialgine
TM, Cecalgum
TM or Algogel
TM by the company Cargill Products, under the name Protanal
TM by the company FMC Biopolymer, under the name
Alginate by the company Danisco, under the name Kimica Algin by the company Kimica, and under the names
and
by the company ISP.
Aqueous phase
The second composition according to the present invention comprises at least one aqueous phase.
The at least one aqueous phase comprises water.
The aqueous phase may also comprise water-miscible organic solvents (at room temperature: 25℃) , for instance monoalcohols containing from 2 to 6 carbon atoms, such as ethanol or isopropanol; polyols especially containing from 2 to 20 carbon atoms, preferably containing from 2 to 10 carbon atoms and preferentially containing from 2 to 6 carbon atoms, such as glycerol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol or diethylene glycol; glycol ethers (especially containing from 3 to 16 carbon atoms) such as mono-, di- or tri-propylene glycol (C
1-C
4) alkyl ethers, mono-, di- or tri-ethylene glycol (C
1-C
4) alkyl ethers, and mixtures thereof.
The aqueous phase may also comprise any water-soluble or water-dispersible compound that is compatible with an aqueous phase, such as hydrophilic gelling agents, preservatives or surfactants, and mixtures thereof.
In particular, the second composition of the present invention may comprise the at least one aqueous phase in a content ranging from 10%to 99%by weight, especially from 50%to 99%by weight, and more particularly from 70%to 99%by weight, relative to the total weight of the second composition.
Hydrophilic gelling agent
The second composition according to the present invention may comprise optionally at least one additional hydrophilic gelling agent.
For the purposes of the present invention, the term "hydrophilic gelling agent" means a compound that is capable of gelling the aqueous phase, without combining with the polyvalent metal ions from the first composition.
The gelling agent may be water-soluble or water-dispersible.
More specifically, the hydrophilic gelling agent may be chosen from synthetic polymeric gelling agents, polymeric gelling agents that are natural or of natural origin, or a mixture thereof.
Synthetic polymeric gelling agents
For the purposes of the present invention, the term "synthetic" means that the polymer is neither naturally existing nor a derivative of a polymer of natural origin.
The synthetic polymeric gelling agent under consideration according to the present invention may or may not be particulate.
For the purposes of the present invention, the term "particulate" , when being used for the synthetic polymeric gelling agent, means that the polymer is in the form of particles, preferably spherical particles.
More specifically, these polymers may be chosen especially from:
modified or unmodified carboxyvinyl polymers, such as the products sold under the name
(CTFA name: Carbomer) by the company Goodrich; polyacrylates, polymethacrylates such as the products sold under the names Lubrajel
TM and Norgel by the company Guardian or under the name
by the company Hispano Chimica; polyacrylamides; optionally crosslinked and/or neutralized 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, for instance the poly (2-acrylamido-2-methylpropanesulfonic acid) sold by the company Clariant under the name Hostacerin
(CTFA name: ammonium polyacryldimethyltauramide) ; crosslinked anionic copolymers of acrylamide and of
which are in the form of a W/O emulsion, such as those sold under the name Sepigel
TM 305 (CTFA name: Polyacrylamide/C
13-14 isoparaffin/Laureth-7) and under the name Simulgel
TM 600 (CTFA name: Acrylamide/Sodium acryloyldimethyltaurate copolymer/Isohexadecane/Polysorbate 80) by the company SEPPIC; and mixtures thereof.
Preferably, these polymers may be chosen from Acrylates/C
10-30 Alkyl Acrylate Crosspolymer such as,
ultrez 20,
ultrez 21, Permulen
TM TR-1, Permulen
TM TR-2,
1382,
ETD 2020, Carbomer such as
K,
980, Ammonium acryloyldimethyl Taurate/Steareth-8 Methacrylate copolymer such as
SNC, Acrylates copolymer such as
Aqua SF-1, Ammonium acryloyldimethyl taurate/steareth-25 Methacrylate Crosspolymer such as
HMS, Ammonium acryloyldimethyl taurate such as
AVC.
Preferably, these polymers may be chosen from carboxyvinyl polymers such as the
products (carbomers) such as
Ultrez 20 Polymer marketed by Lubrizol and the Pemulen products (acrylate/C
10-30 alkylacrylate copolymer) ; polyacrylamides, for instance the crosslinked copolymers marketed under the trademarks Sepigel
TM 305 (CTFA name: polyacrylamide/C
13-14 isoparaffin/Laureth-7) or Simulgel
TM 600 (CTFA name: acrylamide/sodium acryloyldimethyltaurate copolymer/isohexadecane/polysorbate 80) by SEPPIC; 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, which are optionally crosslinked and/or neutralized, for instance the poly (2-acrylamido-2-methylpropanesulfonic acid) marketed by Hoechst under the trademark Hostacerin
(CTFA name: ammonium polyacryloyldimethyltaurate) or Simulgel
TM 800 marketed by SEPPIC (CTFA name: sodium polyacryloyldimethyltaurate/polysorbate 80/sorbitan oleate) ; copolymers of 2-acrylamido-2-methylpropanesulfonic acid and of hydroxyethyl acrylate, for instance Simulgel
TM NS and Sepinov EMT 10 marketed by SEPPIC; and mixtures thereof.
Preferably, these polymers may be chosen from glyceryl acrylate/acrylic acid copolymers available from ISP Technologies, Inc. (United Guardian Inc. ) under the tradename Lubrajel
TM, particular the form known as Lubrajel
TM oil which contains about 1.0%-1.3%glyceryl acrylate/acrylic acid copolymer in aqueous glycerin (about 40%glycerin) . Lubrajel
TM oil also includes about 0.6%PVM/MA copolymer (also known as methoxyethylene/maleic anhydride copolymer) .
Polymeric gelling agents that are natural or of natural origin
For the purposes of the present invention, the term "of natural origin" is intended to denote polymeric gelling agents obtained by modification of natural polymeric gelling agents.
These gelling agents may be particulate or non-particulate.
More specifically, these gelling agents fall within the category of polysaccharides.
In general, polysaccharides that are suitable for use in the present invention may be homopolysaccharides such as fructans, glucans, galactans and mannans or heteropolysaccharides such as hemicellulose.
Similarly, they may be linear polysaccharides such as pullulan or branched polysaccharides such as gum arabic and amylopectin, or mixed polysaccharides such as starch.
In general, the polysaccharides may be chosen from ones produced by microorganisms; polysaccharides isolated from algae, and higher plant polysaccharides, such as homogeneous polysaccharides, in particular celluloses and derivatives thereof or fructosans, heterogeneous polysaccharides such as gum arables, galactomannans, glucomannans, and derivatives thereof; and mixtures thereof.
In particular, the polysaccharides may be chosen from fructans, gellans, glucans, amylose, amylopectin, glycogen, pullulan, dextrans, celluloses and derivatives thereof, in particular methylcelluloses, hydroxyalkylcelluloses, ethylhydroxyethylcelluloses and carboxymethylcelluloses, mannans, xylans, lignins, arabans, galactans, galacturonans, chitin, chitosans, glucuronoxylans, arabinoxylans, xyloglucans, glucomannans, arabinogalactans, glycosaminoglucans, gum arables, tragacanth gums, ghatti gums, locust bean gums, galactomannans such as guar gums and nonionic derivatives thereof, in particular hydroxypropyl guar, and ionic derivatives thereof, biopoly saccharide gums of microbial origin, in particular scleroglucan or xanthan gums, mucopolysaccharides, and in particular chondroitin sulfates, and mixtures thereof. These polysaccharides may be chemically modified, especially with urea or urethane groups or by hydrolysis, oxidation, esterification, etherification, sulfatation, phosphatation, amination, amidation or alkylation reaction, or by several of these modifications.
The derivatives obtained may be anionic, cationic, amphoteric or nonionic.
Advantageously, the polysaccharides may be chosen from xanthan gum, scleroglucan gum, guar gum, inulin and pullulan, and mixtures thereof.
In general, the compounds of this type that may be used in the present invention are chosen from those described especially in Kirk-Othmer's Encyclopedia of Chemical Technology, Third Edition, 1982, volume 3, pp. 896-900, and volume 15, pp. 439-458, in Polymers in Nature by E.A. MacGregor and C.T. Greenwood, published by John Wiley&Sons, Chapter 6, pp. 240-328, 1980, in the book by Robert L. Davidson entitled Handbook of Water-Soluble Gums and Resins published by McGraw Hill Book Company (1980) and in Industrial Gums-Polysaccharides and their Derivatives, edited by Roy L. Whistler, Second Edition, published by Academic Press Inc.
More precisely, these polysaccharides that are suitable for use in the present invention may be distinguished according to whether they are derived from microorganisms, from algae or from higher plants, and are detailed below.
Polysaccharides produced by microorganisms
Xanthan
Xanthan is a heteropolysaccharide produced at the industrial scale by the aerobic fermentation of the bacterium Xanthomonas campestris. Its structure consists of a main chain of β (1, 4) -linked β-D-glucoses, similar to cellulose. One glucose molecule in two bears a trisaccharide side chain composed of an α-D-mannose, a β-D-glucuronic acid and a terminal β-D-mannose. The internal mannose residue is generally acetylated on carbon 6. About 30%of the terminal mannose residues bear a pyruvate group linked in chelated form between carbons 4 and 6. The charged pyruvic acids and glucuronic acids are ionizable, and are thus responsible for the anionic nature of xanthan (negative charge down to a pH equal to 1) . The content of pyruvate and acetate residues varies according to the bacterial strain, the fermentation process, the conditions after fermentation and the purification steps. These groups may be neutralized in commercial products with Na
+, K
+ or Ca
2+ ions (Satia company, 1986) . The neutralized form may be converted into the acid form by ion exchange or by dialysis of an acidic solution.
Xanthan gums have a molecular weight of between 1 000 000 and 50 000 000 and a viscosity of between 0.6 and 1.65 Pa. s for an aqueous composition containing 1%of xanthan gum (measured at 25℃ on a Brookfield viscometer of LVT type at 60 rpm) .
Xanthan gums are represented, for example, by the products sold under the names Rhodicare by the company Rhodia Chimie, under the name Satiaxane
TM by the company Cargill Texturizing Solutions (for the food, cosmetic and pharmaceutical industries) , under the name Novaxan
TM by the company ADM, and under the names
and
by the company CP-Kelco.
Pullulan
Pullulan is a polysaccharide consisting of maltotriose units, known under the name α (1, 4) -α (1, 6) -glucan. Three glucose units in maltotriose are connected via an α (1, 4) glycoside bond, whereas the consecutive maltotriose units are connected to each other via an α (1, 6) glycoside bond.
Pullulan is produced, for example, under the reference Pullulan PF 20 by the group Hayashibara in Japan.
Dextran and dextran sulfate
Dextran is a neutral polysaccharide not bearing any charged groups, which is biologically inert, prepared by fermentation of beet sugar containing solely hydroxy groups. It is possible to obtain dextran fractions of different molecular weights from native dextran by hydrolysis and purification. Dextran may in particular be in the form of dextran sulfate.
Dextran is represented, for example, by the products sold under the name Dextran or Dextran T by the company Pharmacosmos, or under the name Dextran 40 Powder or Dextran 70 Powder by the company Meito Sangyo Co. Dextran sulfate is sold by the company PK Chemical A/S under the name Dextran sulfate.
Succinoglycan
Succinoglycan is an extracellular polymer of high molecular weight produced by bacterial fermentation, consisting of octasaccharide repeating units (repetition of 8 sugars) . Succinoglycans are sold, for example, under the name Rheozan by the company Rhodia. Scleroglucan
Scleroglucan is a nonionic branched homopolysaccharide consisting of β-D-glucan units. The molecules consist of a linear main chain formed from D-glucose units linked via β (1, 3) bonds and of which one in three is linked to a side D-glucose unit via a β (1, 6) bond.
A more complete description of scleroglucans and of their preparation may be found in patent US 3 301 848.
Scleroglucan is sold, for example, under the name Amigel by the company Alban Miiller, or under the name Actigum
TM CS by the company Cargill.
Polysaccharides isolated from algae
Furcellaran
Furcellaran is obtained commercially from red algae Furcellaria fasztigiata. Furcellaran is produced, for example, by the company Est-Agar.
Polysaccharides of higher plants
This category of polysaccharides may be divided into homogeneous polysaccharides (only one saccharide species) and heterogeneous polysaccharides composed of several types of saccharides.
a) Homogeneous polysaccharides and derivatives thereof
The polysaccharide according to the present invention may be chosen from celluloses and derivatives or fructosans.
Cellulose and derivatives
The polysaccharide according to the present invention may also be a cellulose or a derivative thereof, especially cellulose ethers or esters (e.g. methylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxymethylpropylcellulose, cellulose acetate, cellulose nitrate, nitrocellulose) .
The present invention may also contain a cellulose-based associative polymer.
According to the present invention, the term "cellulose-based compound'means any polysaccharide compound bearing in its structure linear sequences of anhydroglucopyranose residues (AGU) linked together via β (1, 4) bonds. The repeating unit is the cellobiose dimer. The AGUs are in chair conformation and bear 3 hydroxy functions: 2 secondary alcohols (in position 2 and 3) and a primary alcohol (in position 6) . The polymers thus formed combine together via intermolecular bonds of hydrogen bond type, thus giving the cellulose a fibrillar structure (about 1500 molecules per fibre) .
The degree of polymerization differs enormously depending on the origin of the cellulose; its value may range from a few hundred to several tens of thousands.
The hydroxy groups of cellulose may react partially or totally with various chemical reagents to give cellulose derivatives having intrinsic properties. The cellulose derivatives may be anionic, cationic, amphoteric or nonionic. Among these derivatives, cellulose ethers, cellulose esters and cellulose ester ethers are distinguished.
Among the nonionic cellulose ethers, mention may be made of alkylcelluloses such as methylcelluloses and ethylcelluloses; hydroxyalkylcelluloses such as hydroxymethylcelluloses, hydroxyethylcelluloses and hydroxypropylcelluloses; and mixed hydroxyalkylalkylcelluloses such as hydroxypropylmethylcelluloses, hydroxy-ethylmethylcelluloses, hydroxy ethylethylcelluloses and hydroxybutylmethylcelluloses.
According to the present invention, the hydroxyalkylcellulose, as a nonionic cellulose ether, belongs to the category of nonionic polysaccharide, such that it can be useful as the water soluble polyhydroxy polymerto soften fibers rich in hydroxy groups. So, according to an embodiment of the invention, the first composition comprises fibers rich in hydroxy groups, and the second composition comprises hydroxyalkylcelluloses.
Among the anionic cellulose ethers, mention may be made of carboxyalkylcelluloses and salts thereof. By way of example, mention may be made of carboxymethylcelluloses, carboxymethylmethylcelluloses and carboxymethylhydroxy-ethylcelluloses and sodium salts thereof.
Among the cationic cellulose ethers, mention may be made of crosslinked or non-crosslinked, quaternized hydroxyethylcelluloses.
The quaternizing agent may in particular be glycidyltrimethylammonium chloride or a fatty amine such as laurylamine or stearylamine. Another cationic cellulose ether that may be mentioned is hydroxy ethylcellulosehydroxypropyltrimethylammonium.
The quaternized cellulose derivatives are, in particular:
- quaternized celluloses modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof,
- quaternized hydroxyethylcelluloses modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof.
The alkyl radicals borne by the above quaternized celluloses or hydroxyethylcelluloses preferably contain from 8 to 30 carbon atoms. The aryl radicals preferably denote phenyl, benzyl, naphthyl or anthryl groups.
Examples of quaternized alkylhydroxyethylcelluloses containing C
8-30 fatty chains that may be indicated include the products Quatrisoft LM 200, Quatrisoft LM-X 529-18-A, Quatrisoft LM-X 529-18B (C
12 alkyl) and Quatrisoft LM-X 529-8 (C
18 alkyl) sold by the company Amerchol and the products Crodacel QM, Crodacel QL (C
12 alkyl) and Crodacel QS (C
18 alkyl) sold by the company Croda.
Among the cellulose derivatives, mention may also be made of:
- celluloses modified with groups comprising at least one fatty chain, for instance hydroxyethylcelluloses modified with groups comprising at least one fatty chain, such as alkyl groups, especially of C
8-22, arylalkyl and alkylaryl groups, such as Natrosol Plus Grade 330 CS (C
16 alkyls) sold by the company Aqualon, and
- celluloses modified with polyalkylene glycol alkylphenyl ether groups, such as the product Amercell Polymer HM-1500 (nonylphenyl polyethylene glycol (15) ether) sold by the company Amerchol.
Among the cellulose esters are mineral esters of cellulose (cellulose nitrates, sulfates, phosphates, etc. ) , organic cellulose esters (cellulose monoacetates, triacetates, amidopropionates, acetatebutyrates, acetatepropionates and acetatetrimellitates, etc. ) , and mixed organic/mineral esters of cellulose, such as cellulose acetatebutyrate sulfates and cellulose acetatepropionate sulfates. Among the cellulose ester ethers, mention may be made of hydroxypropylmethylcellulose phthalates and ethylcellulose sulfates.
The cellulose-based compounds of the present invention may be chosen from unsubstituted celluloses and substituted celluloses. The celluloses and derivatives are represented, for example, by the products sold under the names
(microcrystalline cellulose, MCC) by the company FMC Biopolymers, under the name Cekol (carboxymethylcellulose) by the company Noviant (CP-Kelco) , under the name Akucell AF(sodium carboxymethylcellulose) by the company Akzo Nobel, under the name Methocel
TM (cellulose ethers) and Ethocel
TM (ethylcellulose) by the company Dow, and under the names
(carboxymethylcellulose and sodium carboxymethylcellulose) ,
(methylcellulose) , Blanose
TM (carboxymethylcellulose) ,
(methylcellulose, hydroxypropylmethylcellulose) ,
(hydroxypropylcellulose) ,
(cetylhydroxyethylcellulose) and
CS (hydroxy ethylcellulose) by the company Hercules Aqualon.
Fructosans
The polysaccharide according to the present invention may especially be a fructosan chosen from inulin and derivatives thereof (especially dicarboxy and carboxymethyl inulins) .
Fructans or fructosans are oligosaccharides or polysaccharides comprising a sequence of anhydrofructose units optionally combined with several saccharide residues other than fructose. Fructans may be linear or branched. Fructans may be products obtained directly from a plant or microbial source or alternatively products whose chain length has been modified (increased or decreased) by fractionation, synthesis or hydrolysis, in particular enzymatic. Fructans generally have a degree of polymerization from 2 to about 1000 and preferably from 2 to about 60.
Three groups of fructans are distinguished. The first group corresponds to products whose fructose units are for the most part linked via β (2, 1) bonds. These are essentially linear fructans such as inulins.
The second group also corresponds to linear fructoses, but the fructose units are essentially linked via β (2, 6) bonds. These products are levans.
The third group corresponds to mixed fructans, i.e. containing β (2, 6) and β (2, 1) sequences. These are essentially branched fructans, such as graminans.
The preferred fructans in the compositions according to the present invention are inulins. Inulin may be obtained, for example, from chicory, dahlia or Jerusalem artichoke, preferably from chicory.
In particular, the polysaccharide, especially the inulin, has a degree of polymerization from 2 to about 1000 and preferably from 2 to about 60, and a degree of substitution of less than 2 on the basis of one fructose unit.
The inulin used for the present invention is represented, for example, by the products sold under the name Beneo
TM inulin by the company Orafti, and under the name
by the company Sensus.
b) Heterogeneous polysaccharides and derivatives thereof
The polysaccharides that may be used according to the present invention may be gums, for instance cassia gum, karaya gum, konjac gum, gum tragacanth, tara gum, acacia gum or gum arabic.
Gum arabic
Gum arabic is a highly branched acidic polysaccharide which is in the form of mixtures of potassium, magnesium and calcium salts. The monomer elements of the free acid (arabic acid) are D-galactose, L-arabinose, L-rhamnose and D-glucuronic acid.
Galactomannans (guar, locust bean, fenugreek, tara gum) and derivatives (guar phosphate, hydroxypropyl guar, etc. )
Galactomannans are nonionic polyosides extracted from the endosperm of leguminous seeds, of which they constitute the storage carbohydrate.
Galactomannans are macromolecules consisting of a main chain of β (1, 4) -linked D-mannopyranose units, bearing side branches consisting of a single D-galactopyranose unit α (1, 6) -linked to the main chain. The various galactomannans differ, firstly, by the proportion of α-D-galactopyranose units present in the polymer, and secondly, by significant differences in terms of distribution of galactose units along the mannose chain.
The mannose/galactose (M/G) ratio is about 2 for guar gum, 3 for tara gum and 4 for locust bean gum.
Guar
Guar gum is characterized by a mannose/galactose ratio of the order of 2/1. The galactose group is regularly distributed along the mannose chain.
The guar gums that may be used according to the present invention may be nonionic, cationic or anionic. According to the present invention, use may be made of chemically modified or unmodified nonionic guar gums.
The unmodified nonionic guar gums are, for example, the products sold under the names Vidogum GH, Vidogum G and Vidocrem by the company Unipektin and under the name Jaguar by the company Rhodia, under the name
Guar by the company Danisco, under the name Viscogum
TM by the company Cargill, and under the name
guar gum by the company Aqualon.
The hydrolysed nonionic guar gums that may be used according to the present invention are represented, for example, by the products sold under the name
by the company Danisco.
The modified nonionic guar gums that may be used according to the present invention are preferably modified with C
1-6 hydroxyalkyl groups, among which mention may be made, for example, of hydroxymethyl, hydroxyethyl, hydroxypropyl and hydroxybutyl groups.
Such nonionic guar gums optionally modified with hydroxyalkyl groups are sold, for example, under the trade names Jaguar HP 60, Jaguar HP 105 and Jaguar HP 120 (hydroxypropyl guar) by the company Rhodia or under the name
HP (hydroxypropyl guar) by the company Aqualon.
The cationic galactomannan gums preferably have a cationic charge density of less than or equal to 1.5 meq. /g, more particularly between 0.1 and 1 meq. /g. The charge density may be determined by the Kjeldahl method. It generally corresponds to a pH of the order of 3 to 9.
In general, for the purposes of the present invention, the term "cationic galactomannan gum" means any galactomannan gum containing cationic groups and/or groups that can be ionized into cationic groups.
The preferred cationic groups are chosen from those comprising primary, secondary, tertiary and/or quaternary amine groups.
The cationic galactomannan gums used generally have a weight-average molecular mass of between 500 and 5×10
6 approximately and preferably between 10
3 and 3×10
6 approximately.
The cationic galactomannan gums that may be used according to the present invention are, for example, gums comprising tri (C
1-4) alkylammonium cationic groups. Preferably, 2%to 30%by number of the hydroxy functions of these gums bear trialkylammonium cationic groups.
Among these trialkylammonium groups, mention may be made most particularly of trimethylammonium and triethylammonium groups.
Even more preferentially, these groups represent from 5%to 20%by weight relative to the total weight of the modified galactomannan gum.
According to the present invention, the cationic galactomannan gum is preferably a guar gum comprising hydroxypropyltrimethylammonium groups, i.e. a guar gum modified, for example, with 2, 3-epoxypropyltrimethylammonium chloride.
These galactomannan gums, in particular guar gums modified with cationic groups are products already known per se and are, for example, described in patents US 3 589 578 and US 4 031 307. Such products are moreover sold especially under the trade names Jaguar EXCEL, Jaguar C13 S, Jaguar C 15, Jaguar C 17 and Jaguar CI 62 (Guar Hydroxypropyltrimonium Chloride) by the company Rhodia, under the name
Guar (Guar Hydroxypropyltrimonium Chloride) by the company Degussa, and under the name
3000 (Guar Hydroxypropyltrimonium Chloride) by the company Aqualon.
The anionic guar gums that may be used according to the present invention are polymers comprising groups derived from carboxylic, sulfonic, sulfenic, phosphoric, phosphonic or pyruvic acid. The anionic group is preferably a carboxylic acid group. The anionic group may also be in the form of an acid salt, especially a sodium, calcium, lithium or potassium salt.
The anionic guar gums that may be used according to the present invention are preferentially carboxymethyl guar derivatives (carboxymethyl guar or carboxymethyl hydroxypropyl guar) .
Locust bean
Locust bean gum is extracted from the seeds of the locust bean tree Ceratonia siliqua) .
The unmodified locust bean gum that may be used in the present invention is sold, for example, under the name Viscogum
TM by the company Cargill, under the name Vidogum L by the company Unipektin and under the name
LBG by the company Danisco.
The chemically modified locust bean gums that may be used in the present invention may be represented, for example, by the cationic locust beans sold under the name Catinal CLB (locust bean hydroxypropyltrimonium chloride) by the company Toho.
Tara gum
The tara gum that may be used in the context of the present invention is sold, for example, under the name Vidogum SP by the company Unipektin.
Glucomannans (konjac gum)
Glucomannan is a polysaccharide of high molecular weight (500 000<Mglucomannan<2 000 000) composed of D-mannose and D-glucose units with a branch every 50 or 60 units approximately. It is found in wood, but is also the main constituent of konjac gum. Konjac (Amorphophallus konjac) is a plant of the Araceae family.
The products that may be used according to the present invention are sold, for example, under the names
and
by the company Shimizu.
Other polysaccharides
Among the other polysaccharides that may be used according to the present invention, mention may also be made of chitin (poly-N-acetyl-D-glucosamine, β (1, 4) -2-acetamido-2-deoxy-D-glucose) , chitosan and derivatives (chitosan-β-glycerophosphate, carboxymethylchitin, etc. ) such as those sold by the company France-Chitine; glycosaminoglycans (GAG) such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, and preferably hyaluronic acid; xylans (or arabinoxylans) and derivatives.
Arabinoxylans are polymers of xylose and arabinose, all grouped under the name pentosans. Xylans consist of a main chain of β (1, 4) -linked D-xylose units and on which are found three substituents (Rouau&Thibault, 1987) : acid units, α-L-arabinofuranose units, side chains which may contain arabinose, xylose, galactose and glucuronic acid.
According to this variant, the polysaccharide is preferably hyaluronic acid, or a salt thereof.
The at least one hydrophilic gelling agent may be present in an amount ranging for example from 0.001 to 10%by weight, preferably 0.01 to 5%by weight and more preferably from 0.05 to 3%by weight relative to the total weight of the second composition.
Active agents
According to an embodiment of the present invention, the first composition may comprise at least one active agent.
According to an embodiment of the present invention, the second composition may comprise at least one active agent.
When the first composition includes the at least one active agent, it may be incorporated into the first composition in particular by means of an alternating electric field. The active agent (s) may be incorporated in particular in the powder state.
Amongst all of the active agents that can be used in the present invention, particular mention can be made of: α- or β-hydroxy acids such as lactic acid, glycolic acid, citric acid, 5-octanoylsalicyclic acid, α-hydroxydecanoic acid, α-hydroxylauric, tartaric acid, glucuronic acid, galacturonic acid, acrylic acid, α-hydroxybutyric acid, α-hydroxyisobutyric acid, malic acid, mandelic acid, phosphoric acid, pyruvic acid, lactobionic acid, and salicylic acid.
It is also possible to use anti-acne agents, such as salicylic acid or benzoyl peroxide, octopirox, dextrorotary and levorotary sulfur-containing amino acids, their salts, and their N-acetyl derivatives such as N-acetyl cysteine, or agents seeking to prevent aging of the skin and/or to improve its state, for example the above-mentioned α-and β-hydroxy acids, retinoids such as retinoic acid, retinol, and its esters, such as, for example, retinyl propionate, and retinyl acetate, or retinyl palmitate, niacinamide, allantoin, extracts of aloe, azelaic acid, bisabolol, phytic acid, collagen, or agents stimulating the formation of collagen, vitamins such as vitamin C or derivatives thereof, such as ascorbyl glucoside, vitamin E or derivatives thereof, vitamin A or derivatives thereof, vitamin F or derivatives thereof, dextrorotary and levorotary sulfur-containing amino acids and derivatives thereof as mentioned above, elastin, N-acetyl D-glucosamine, luteolin, or antioxidants such as green tea or active fractions thereof, glycerin, laponite, caffeine, essential aromatic oils, coloring agents, free-radical scavengers, moisturizers, depigmenting agents, agents for improving the color of the skin such as artificial-tanning agents of the dihydroxyacetone or tyrosin ester type, liporegulators, softeners, anti-wrinkle agents, keratolytic agents, fresheners, deodorants, anesthetics, nourishing agents, and mixtures thereof. It is also possible to use bleaching agents such as kojic acid, ascorbyl phosphates, ascorbyl glucosides, ascorbic acid, and mixtures thereof.
It is also possible to use active agents for improving the condition of the skin in the case of mask, such as moisturizers or agents serving to improve the natural lipid barrier, such as ceramides, cholesterol sulfates, and/or fatty acids, and mixtures thereof. It is also possible to use enzymes that have activity on the skin, such as proteases, lipases, cerebrosidases, and/or melanases, and mixtures thereof.
As other examples of active agents that can be suitable for implementing the present invention there are agents for drugs, peptides, proteins, detectable labels, contrast reagents, pain-killing, anesthetics, antibacterial agents, anti-yeast agents, antifungal agents, antiviral agents, anti-dermititis agents, anti-pruritic agents, anti-emetics, vascular protectors, agents against motion sickness, anti-irritants, anti-inflammatory agents, immunomodulators, anti-hyperkeratolytic agents, agents for treating dry skin, antiperspirants, anti-psoriatic agents, antidandruff agents, anti-aging agents, anti-asthmatic agents and bronchodilators, sunscreen agents, antihiistamnes, healing agents, corticosteroids, tanning agents, and mixtures thereof.
The content of the at least one active agent in the first composition and/or in the second composition may be adjusted as a function of the intended purpose of the kit.
Alkali metal hyaluronic compound
Hyaluronic compound may be also used as an active agent according to the present invention. The hyaluronic compound is preferably an alkali metal hyaluronic compound.
The term "alkali metal hyaluronic compound" in particular means alkali metal salts of hyaluronic acid (hyaluronates) or derivatives thereof. The alkali metal hyaluronic compound is water-soluble.
In the context of the present invention, the term "hyaluronic acid or derivatives thereof" covers in particular the basic unit of hyaluronic acid of formula:
It is the smallest fraction of hyaluronic acid comprising a disaccharide dimer, namely D-glucuronic acid and N-acetylglucosamine.
The term "hyaluronic acid or derivatives thereof" also comprises, in the context of the present invention, the linear polymer comprising the polymeric unit described above, linked together in the chain via alternating β (1, 4) and β (1, 3) glycosidic linkages, having a molecular weight (Mw) that can range between 380 and 13 000 000 daltons. This molecular weight depends in large part on the source from which the hyaluronic acid is obtained and/or on the preparation methods.
In the natural state, hyaluronic acid is present in pericellular gels, in the base substance of the connective tissues of vertebrate organs such as the dermis and epithelial tissues, and in particular in the epidermis, in the synovial fluid of the joints, in the vitreous humor, in the human umbilical cord and in the crista galli apophysis.
Thus, the term "hyaluronic acid or derivatives thereof" comprises all the fractions or subunits of hyaluronic acid having a molecular weight in particular within the molecular weight range recalled above.
By way of illustration of the various hyaluronic acid fractions, reference may be made to the document "Hyaluronan fragments: an information-rich system" , R. Stern et al., European Journal of Cell Biology 58 (2006) 699-715, which reviews the listed biological activities of hyaluronic acid according to its molecular weight.
According to a preferred embodiment of the present invention, the hyaluronic acid fractions suitable for the use covered by the present invention have a molecular weight of between 50 000 and 5 000 000, in particular between 100 000 and 5 000 000, especially between 400 000 and 5 000 000 Da. In this case, the term used is high-molecular-weight hyaluronic acid.
Alternatively, the hyaluronic acid fractions that may also be suitable for the use covered by the present invention have a molecular weight of between 50 000 and 400 000 Da. In this case, the term used is intermediate-molecular-weight hyaluronic acid.
Alternatively again, the hyaluronic acid fractions that may be suitable for the use covered by the present invention have a molecular weight of less than 50 000 Da. In this case, the term used is low-molecular-weight hyaluronic acid.
Finally, the term "hyaluronic acid or derivatives thereof" also comprises hyaluronic acid esters in particular those in which all or some of the carboxylic groups of the acid functions are esterified with oxyethylenated alkyls or alcohols, containing from 1 to 20 carbon atoms, in particular with a degree of substitution at the level of the D-glucuronic acid of the hyaluronic acid ranging from 0.5 to 50%.
More specifically, hyaluronic acid or hyaluronates may be reacted with an alkylene oxide, such as ethylene oxide or propylene oxide, to form polyglycol hyaluronates. The polyglycol segment is bonded to hyaluronic acid through the carboxyl group (s) . Typically, hyaluronic acid or hyaluronates react with propylene oxide to form polypropylene glycol hyaluronates, while react with ethylene oxide to form polyethylene glycol hyaluronates.
Further, mention may be made of methyl, ethyl, n-propyl, n-pentyl, benzyl and dodecyl esters of hyaluronic acid. Such esters have in particular been described in D. Campoccia et al. "Semisynthetic resorbable materials from hyaluronan esterification" , Biomaterials 19 (1998) 2101-2127.
The molecular weights indicated above are also valid for the hyaluronic acid esters.
Adjuvants
In a known manner, the second composition of the present invention may also contain adjuvants that are common in cosmetics and/or dermatology, such as preserving agents, antioxidants, pH modifiers (acidic or basic) , fragrances, fillers, bactericides, odour absorbers, colorants (pigments and dyes) , emulsifiers, and also lipid vesicles.
Needless to say, a person skilled in the art will take care to select this or these optional additional compound (s) , and/or the amount thereof, such that the benefits of the second composition according to the present invention are not, or are not substantially, adversely affected by the envisaged addition.
Galenic form
The second composition according to the present invention may be in various forms, in particular in the form of aqueous solution, dispersion, or emulsion, especially such as a water/oil or oil/water emulsion or multiple emulsions.
An emulsion may have an oily or aqueous continuous phase. Such an emulsion may be, for example, an inverse (W/O) emulsion or a direct (O/W) emulsion, or alternatively a multiple emulsion (W/O/W or O/W/O) .
In the case of emulsions, direct (O/W) emulsions are preferred.
In particular, the second composition according to the present invention may be in the form of an oil-in-water (O/W) emulsion, water-in-oil (W/O) emulsion, or a multiple emulsion, preferably a oil-in-water (O/W) emulsion.
The second composition of the present invention is preferably an aqueous solution.
According to a preferred embodiment of the present invention, the kit presents as a mask comprising:
1) a nonwoven fabric (or tissue) made of fibers rich in hydroxy groups, comprising from 0.01%to 5%by weight, preferably from 0.02%to 1%by weight, or preferably from 0.04%to 0.5%, of calcium sulphate or calcium carbonate, and from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, of HEC or HPC, relative to the total weight of the nonwoven fabric, and
2) a composition comprising from 10%to 99%by weight, preferably from 50%to 99%by weight, of the at least one aqueous phase, from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, of sodium alginate, and from 0.1%to 0.5%by weight, preferably from 0.2%to 0.4%by weight, of sodium citrate, relative to the total weight of the composition,
wherein the weight ratio of the nonwoven fabric to the composition ranges from 1: 3 to 1: 20, preferably from 1: 8 to 1: 15.
Varied embodiment of the Kit
Based on the discussions for the kit comprising the first composition and the second composition according to the present invention, it is to be understood that the following embodiment is also within the spirit of the present invention.
Specifically, according to the present invention, there is provided a mask package 1, comprising:
1) a first composition comprising at least one water insoluble salt of polyvalent metal and at least one water soluble polyhydroxy polymer, and
2) a fourth composition, which is free of water, comprising:
a) at least one water soluble chelating agent of the polyvalent metal ion, and
b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion
wherein the first composition and the fourth composition are separately placed from one another.
For this mask package 1, the first composition as well as the components thereof, including the water insoluble salt and the water soluble polyhydroxy polymer, and the fourth composition, including the water soluble chelating agent, the water soluble gelatinizing agent and others can be substantially same as the kit of the invention, where the fourth composition corresponds substantially to the second composition, except for the absence of water. Also, the structure of the mask package 1 can be substantially same as the kit of the invention. Further, the amounts of the compositions, the components of the compositions and the ratios therebetween of the mask package 1 can refer to the kit of the present invention.
In order to apply the mask package 1, the fourth composition can be mixed with water to form an aqueous solution of the fourth composition. Obviously, such an aqueous solution is substantially corresponding to the second composition of the kit according to the present invention. Then, the aqueous solution is mixed with the first composition, e.g., referring to the way for mixing the first composition and the second composition of the kit according to the present invention.
In particular, the mask package 1 according to the present invention comprises:
1) a nonwoven fabric (or tissue) comprising from 0.01%to 5%by weight, preferably from 0.02%to 1%by weight, or preferably from 0.04%to 0.5%, of calcium sulphate or calcium carbonate, and from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, of HEC or HPC, relative to the total weight of the nonwoven fabric, and
2) a fourth composition, which is free of water, comprising from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, of the water soluble chelating agent and from 0.1%to 0.5%by weight, preferably from 0.2%to 0.4%by weight, of the water soluble gelatinizing agent, relative to the total weight of the composition,
wherein the weight ratio of the nonwoven fabric to the fourth composition ranges from 1: 3 to 1: 20, preferably from 1: 8 to 1: 15.
Method and use
The first composition and the second/fourth composition according to the present invention can be generally prepared according to the general knowledge of a person skilled in the art. Nevertheless, it is to be understood that a person skilled in the art can choose the method of preparation, on the basis of his/her general knowledge, taking into account the nature of the constituents used, for example, their solubility in the vehicle, and the application envisaged for the compositions or the kit.
According to an embodiment, the kit according to the present invention can be used for caring for keratin materials, especially the face. This use may manifest itself as a process for caring for keratin materials, especially the face, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to said keratin materials the thus obtained mixture as a mask.
According to an embodiment, the kit according to the present invention can be used for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, and so on. This use may manifest itself as a process for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to a location in need of the thus obtained mixture as a mask or stuffing.
Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the present invention are approximations, the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contain certain errors necessarily resulting from the standard deviation found in their respective measurements. The following examples are intended to illustrate the present invention without limiting the scope as a result.
EXAMPLES
The ingredient amounts/concentrations in the compositions/formulas described below are expressed in %by weight, relative to the total weight of each composition/formula.
Example 1
I. Preparation
The invention formulas A and B, and comparative formula A were prepared, as the second composition.
Table 1
In table 1, comparative A doesn’t contain TRISODIUM CITRATE as compared with the invention formula A.
Protocol of preparation of the second composition using the formulas in table 1: all the ingredients were put into beaker, heated to 60℃ and homogenized until uniform, cooled down to room temperature.
Protocol of preparation of masks: 0.75g of each of the formulas A to B and comparative A, respectively, were placed together with a nonwoven fabric with a weight of 1.3g, made of 20%by weight of calcium alginate fiber and 80%of lyocell fiber, sold by the Sanjiang company under the name M762R-40CN.
II. Evaluation of the invention and comparative masks
The present invention and comparative masks were evaluated using the following protocols.
Method for texture transformation evaluation
Five panelists evaluated the gelling area on tissue by visual way and graded from poor to excellent which was classified in the following 4 categories based on the average of the grade: “excellent” (>50%) , “good” (30-50%) , “fair” (10-30%) , or “poor” (<10%) .
Method for fresh feel evaluation
Five panelists evaluated the degree of greasiness of skin by the tactile way when slight moving finger pulp on the face.
Evaluation process: Apply the mask on face for 15 minutes and then take off and massage the skin. Perceive the greasiness of skin by moving finger pulp on the face. Then each panelist gave the score from 0 to 15. The less greasiness, the high score was given.
Evaluation index: We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
Method for skin adhesion evaluation
Five panelists evaluated the degree of mask adhered on face, the level of bubbles around eye, nose and mouth by visual way with a mirror under the standardized light.
Evaluation process: Apply the mask on face, and observe the quantity of bubbles around eye, nose and mouth. Then each panelist gave the score from 0 to 15. The less bubbles, the high score was given.
Evaluation index: We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
Method for hydration effect evaluation
Five panelists evaluated the hydration effect of the masks, in view of the plumpy, fine line improvement and soft skin that provided by the formulas.
Evaluation process: Apply the mask on face for 15 minutes and then take off and massage the skin. Observe the degree of lines on forehead and nasolabial folds, touch the cheek by index finger and middle figer and perceive the skin softness by tactile way, and observe the degree of fine lines on the cheek. Each panelist gave the score from 0 to 15. The more plumpy skin, the high score was given.
Evaluation Index: We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
Method for moisture delivery capacity evaluation
Five panelists evaluated the quantity of juice left on skin after take-off the mask by visual way with a mirror under the standardized light.
Evaluation process: Apply the mask on face for 15 minutes and then take off. Observe the quantity of juice left on skin by visual way. Then each panelist gave the score from 0 to 15. The more juice left on skin, the higher score was given.
Evaluation index: We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
The results obtained are detailed in the table hereunder:
Table 2
Formula A | Formula B | Comparative Formula A | |
Texture transformation | Good | Excellent | poor |
Skin adhesion | Excellent | Excellent | fair |
Fresh feel | Excellent | Fair | good |
Hydration effect | good | Excellent | fair |
Moisture delivery capacity | excellent | Fair | poor |
III. Conclusion
The mask of the present invention is superior in terms of beneficial properties, e.g. texture transformation, hydration effect and moisture delivery capacity, over the comparative one.
Example 2:
The invention formula C, and comparative formulas B-D were prepared, as the first composition.
Table 3
Protocol of preparation of masks: 0.75g of formula A was placed together with a nonwoven fabric with a weight of 1.3g, made of formula C and comparative formulas B-D, respectively, so as to provide mask C, and comparative masks B-D, respectively.
II. Evaluation of the invention and comparative masks
The present invention and comparative masks were evaluated using the following protocols.
Method for softness evaluation
(1) . Five panelists evaluated the gelling area on tissue by hand touching way and graded from poor to excellent which was classified in the following 3 categories based on the average of the grade: “excellent” (uniformly softened) , “fair” (softened but uniformly) , or “poor” (not softened) .
Table 4
(2) . The softening effect was evaluated indirectly by measuring the deformation of mask, as a softened mask would result in deformation.
Deformation (%) = ( (value measured after fresh mix) - (initial value) ) / (initial value) .
Table 5
Mask C | Comparative mask B | |
Deformation | 13.80% | 8.42% |
III. Conclusion
The mask of the present invention is superior in terms of softness, over the comparative one.
The foregoing description illustrates and describes the present disclosure. Additionally, the disclosure shows and describes only the preferred embodiments of the disclosure, but, as mentioned above, it is to be understood that it is capable of changes or modifications within the scope of the concept as expressed herein, commensurate with the above teachings and/or skill or knowledge of the relevant art. The described hereinabove are further intended to explain best modes known of practicing the disclosure and to enable others skilled in the art to utilize the disclosure in such, or other embodiments and with the various modifications required by the particular applications or uses disclosed herein. Accordingly, the description is not intended to limit the disclosure to the form disclosed herein. Also it is intended that the appended claims be construed to include alternative embodiments.
All publications, patents and patent applications cited in this specification are herein incorporated by reference, and for any and all purposes, as if each individual publication, patent or patent application were specifically and individually indicates to be incorporated by reference. In this case of inconsistencies, the present disclosure will prevail.
Claims (34)
- A kit, comprising:1) a first composition comprising at least one water insoluble salt of polyvalent metal and at least one water soluble polyhydroxy polymer, and2) a second composition comprising at least one aqueous phase, anda) optionally, at least one water soluble chelating agent of the polyvalent metal ion, andb) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion;wherein the first composition and the second composition are separately placed from one another.
- Kit according to the preceding claim 1, wherein the gelatinizing agent is specifically selected to have an ability of combining with the polyvalent metal ions lower than that of the chelating agent.
- Kit according to anyone of the preceding claims, wherein the water insoluble salt of polyvalent metal is chosen from water insoluble salts of calcium, strontium, zinc, copper, manganese, or mixtures thereof.
- Kit according to anyone of the preceding claims, wherein the at least one water insoluble salt of polyvalent metal is a water insoluble salt of calcium chosen from calcium alginate, calcium sulphate and calcium carbonate, or a mixture thereof.
- Kit according to anyone of the preceding claims, wherein the water soluble polyhydroxy polymers comprise polyhydroxycarboxylic acids, esters of the acids; polyhydroxy celluloses or a mixture thereof, preferably hydroxyethylcelluloses, hydroxypropylcelluloses, hydroxy propylmethylcelluloses, hydroxy ethylmethylcelluloses, hydroxy ethylethylcelluloses or hydroxybutylmethylcellulose.
- Kit according to anyone of the preceding claims, wherein the first composition of the present invention comprises the at least one water soluble polyhydroxy polymer in a content ranging from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, relative to the total weight of the first composition.
- Kit according to anyone of the preceding claims, wherein the first composition further comprises additional fibers rich in hydroxy groups, preferably regenerated cellulose or cotton fiber, where the at least one water insoluble salt of polyvalent metal and the at least one water soluble polyhydroxy polymer are loaded to the additional fibers.
- Kit according to claim 7, wherein the water insoluble salt of polyvalent metal is in form of fiber, which, together with one or more additional fibers, forms into a water insoluble substrate, to which substrate the water soluble polyhydroxy polymer is loaded.
- Kit according to claim 8, wherein the water insoluble substrate comprises the water insoluble polyvalent metal salt fiber in an amount ranging from 10%to 80%by weight, especially from 10%to 40%by weight, and comprises the at least one additional fiber in an amount ranging from 10%to 80%by weight, especially from 50%to 80%by weight, relative to the total weight of the water insoluble substrate.
- Kit according to claim 7, wherein the one or more additional fibers forms into a water insoluble substrate, to which substrate both the water insoluble salt of polyvalent metal and the water soluble polyhydroxy polymer are loaded.
- Kit according to claim 10, wherein the water insoluble substrate comprises the water insoluble polyvalent metal salt fiber in an amount ranging from 0.01%to 5%by weight, preferably from 0.02%to 1%by weight, or preferably from 0.04%to 0.5%by weight, relative to the total weight of the water insoluble substrate.
- Kit according to anyone of the preceding claims, wherein the chelating agent of the polyvalent metal ion comprises aminocarboxylic acids, hydroxy carboxylic acids, hydroxy aminocarboxylic acids, polyphosphonic acid, other phosphor-containing organic acid, or a mixture thereof.
- Kit according to anyone of the preceding claims, wherein the at least one water soluble chelating agent is chosen from sodium citrate, disodium EDTA, tetrasodium EDTA, tetrasodium GLDA, trisodium EDDS, sodium phytate, potassium phytate, and mixtures thereof.
- Kit according to anyone of the preceding claims, wherein the at least one water soluble chelating agent of the polyvalent metal ion is present in the second composition from 0.1%to 1%by weight, preferably from 0.2%to 0.4%by weight, relative to the total weight of the second composition.
- Kit according to anyone of the preceding claims, wherein the at least one gelatinizing agent comprises glutins, pectins, gellan gum, carrageenans, agars, alkali metal salts of alginic acid and mixtures thereof.
- Kit according to anyone of the preceding claims, wherein the gelatinizing agent is chosen from alkali metal alginic compounds.
- Kit according to claim 16, wherein the alkali metal alginic compound is chosen from alkali metal alginates, alkali metal salts of alginic acid derivative, or a mixture thereof, preferably from sodium alginate, potassium alginate, lithium alginate, sodium polyethylene glycol alginates, potassium polyethylene glycol alginates, lithium polyethylene glycol alginates, or a mixture thereof.
- Kit according to claim 16, wherein the alkali metal alginic compound is chosen from sodium alginate and potassium alginate, more preferably sodium alginate.
- Kit according to anyone of the preceding claims, wherein the at least one water soluble gelatinizing agent is present in the second composition from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, relative to the total weight of the second composition.
- Kit according to anyone of the preceding claims, wherein the at least one aqueous phase is present in the second composition from 10%to 99%by weight, preferably from 50%to 99%by weight, relative to the total weight of the second composition.
- Kit according to anyone of the preceding claims, wherein the weight ratio of the first composition to the second composition ranges from 1: 3 to 1: 20, preferably from 1: 8 to 1: 15.
- Kit according to anyone of the preceding claims, wherein the second composition comprises at least one hydrophilic gelling agent and/or at least one active agent.
- Kit according to anyone of the preceding claims, wherein the second composition comprises the water soluble polyhydroxy polymers.
- Kit according to anyone of the preceding claims, presenting as a mask comprising:1) a nonwoven fabric made of fibers rich in hydroxy groups, comprising from 0.01%to 5%by weight, preferably from 0.02%to 1%by weight, or preferably from 0.04%to 0.5%, of calcium sulphate or calcium carbonate, and from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, of HEC or HPC, relative to the total weight of the nonwoven fabric, and2) a composition comprising from 10%to 99%by weight, preferably from 50%to 99%by weight, of the at least one aqueous phase, from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, of the water soluble chelating agent and from 0.1%to 0.5%by weight, preferably from 0.2%to 0.4%by weight, of the water soluble gelatinizing agent, relative to the total weight of the composition,wherein the weight ratio of the nonwoven fabric to the composition ranges from 1: 3 to 1: 20, preferably from 1: 8 to 1: 15.
- Kit according to anyone of the preceding claims, wherein the amounts of the chelating agent and the gelatinizing agent are so selected that the molar ratio of the moiety to be released from the chelating agent chelatable with the polyvalent cation to the moiety to be released from the gelatinizing agent gelatinizable with the polyvalent cation ranging from about 10: 1 to about 1: 1, preferably from about 5: 1 to about 2: 1.
- Use of kit according to anyone of the preceding claims for caring for keratin materials, especially the skin, for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects.
- A process for caring for keratin materials, especially the skin, for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, comprising the steps of compounding the first composition and the second composition of the kit according to any one of the preceding claims at a weight ratio of the first composition to the second composition of from 1: 3 to 1: 20, preferably from 1: 8 to 1: 15, and then applying to a location in need of the thus obtained mixture.
- Use of the second composition, as defined in anyone of the preceding claims, as juice or a part of juice for mask product, wherein the mask product comprises, separate from the second composition, afabric or tissue comprising the at least one water insoluble salt of polyvalent metal.
- A mask package 1, comprising:1) a first composition comprising at least one water insoluble salt of polyvalent metal, at least one fiber rich in hydroxy groups, preferably regenerated cellulose or cotton fiber, and at least one water soluble polyhydroxy polymer, where the at least one water soluble polyhydroxy polymer is loaded uniformly to the fibers rich in hydroxy groups, and2) a fourth composition comprising at least one aqueous phase, and,b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ionwherein the first composition and the fourth composition are separately placed from one another.
- Mask package 1 according to claim 29, wherein the water insoluble salt of polyvalent metal is calcium alginate, calcium sulphate or calcium carbonate.
- Mask package 1 according to claim 29 or 30, wherein the water soluble polyhydroxy polymers comprise polyhydroxycarboxylic acids, esters of the acids; polyhydroxy celluloses or a mixture thereof, preferably hydroxyethylcelluloses, hydroxypropylcelluloses, hydroxy propylmethylcelluloses, hydroxy ethylmethylcelluloses, hydroxy ethylethylcelluloses or hydroxybutylmethylcellulose.
- Mask package 1 according to anyone of the preceding claims 29 to 31, wherein the at least one fiber rich in hydroxy groups is chosen from Viscose, Modal, Lyocell, Cupro, Cotton, and mixtures thereof.
- Mask package 1 according to anyone of the preceding claims 29 to 31, wherein the water soluble polyhydroxy polymers are hydroxyethyl cellulose or hydroxypropyl cellulose, or a mixture thereof, and the at least one fiber rich in hydroxy groups is chosen from Viscose, Modal, Lyocell, Cupro, Cotton, and mixtures thereof.
- Mask package 1 according to anyone of the preceding claims 29 to 33, wherein the at least one gelatinizing agent comprises glutins, pectins, gellan gum, carrageenans, agars, alkali metal salts of alginic acid, and mixtures thereof, preferably from sodium alginate and potassium alginate, more preferably sodium alginate.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210758396.0A CN115192473B (en) | 2018-12-29 | 2018-12-29 | Kit for caring skin |
PCT/CN2018/125363 WO2020133361A1 (en) | 2018-12-29 | 2018-12-29 | Kit for caring for the skin |
CN201880100560.0A CN113194908B (en) | 2018-12-29 | 2018-12-29 | Kit for caring skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2018/125363 WO2020133361A1 (en) | 2018-12-29 | 2018-12-29 | Kit for caring for the skin |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020133361A1 true WO2020133361A1 (en) | 2020-07-02 |
Family
ID=71129544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2018/125363 WO2020133361A1 (en) | 2018-12-29 | 2018-12-29 | Kit for caring for the skin |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN115192473B (en) |
WO (1) | WO2020133361A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022205059A1 (en) * | 2021-03-31 | 2022-10-06 | L'oreal | Compositions for caring for skin and a package for containing the same |
WO2022226872A1 (en) * | 2021-04-29 | 2022-11-03 | L'oreal | Kit for caring for the skin |
FR3126303A1 (en) * | 2021-08-25 | 2023-03-03 | L'oreal | Mask for the care of keratinous materials |
WO2023184315A1 (en) * | 2022-03-31 | 2023-10-05 | L'oreal | Kit for caring for keratin materials |
WO2023184295A1 (en) * | 2022-03-31 | 2023-10-05 | L'oreal | Composition for caring for keratin material |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102940583A (en) * | 2012-11-26 | 2013-02-27 | 中国工程物理研究院核物理与化学研究所 | Thermosensitive hydrogel capable of being used as nutrition mask and preparation method of thermosensitive hydrogel |
JP2016222612A (en) * | 2015-06-01 | 2016-12-28 | 昭和電工株式会社 | Cosmetic and skin external preparation |
JP2017052706A (en) * | 2015-09-07 | 2017-03-16 | 一丸ファルコス株式会社 | Cosmetic composition containing granules |
TR201619953A2 (en) * | 2016-12-28 | 2018-07-23 | Buelent Karaagac | TOPICAL THERAPEUTIC FORMULATIONS |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8349301B2 (en) * | 2002-06-04 | 2013-01-08 | The Procter & Gamble Company | Shampoo containing a gel network |
US20060104931A1 (en) * | 2004-11-12 | 2006-05-18 | Takeshi Fukutome | Cosmetic treatment article comprising substrate and gel composition |
FR2940111B1 (en) * | 2008-12-19 | 2012-06-01 | Oreal | KERATINIC MATERIAL COATING KIT COMPRISING A POLYSACCHARIDE AND A IONIC OR DATIVE COMPLEXATION AGENT |
FR3002448B1 (en) * | 2013-02-25 | 2015-04-03 | Oreal | COSMETIC COMPOSITION OF GEL TYPE |
FR3025100B1 (en) * | 2014-08-28 | 2016-12-09 | Oreal | GEL-TYPE COSMETIC COMPOSITION IMPROVED |
FR3030231B1 (en) * | 2014-12-23 | 2018-08-24 | L'oreal | USE OF A FATTY ACID ESTER FOR MATIFYING THE SKIN AND COMPOSITION COMPRISING SAID ESTER |
-
2018
- 2018-12-29 CN CN202210758396.0A patent/CN115192473B/en active Active
- 2018-12-29 WO PCT/CN2018/125363 patent/WO2020133361A1/en active Application Filing
- 2018-12-29 CN CN201880100560.0A patent/CN113194908B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102940583A (en) * | 2012-11-26 | 2013-02-27 | 中国工程物理研究院核物理与化学研究所 | Thermosensitive hydrogel capable of being used as nutrition mask and preparation method of thermosensitive hydrogel |
JP2016222612A (en) * | 2015-06-01 | 2016-12-28 | 昭和電工株式会社 | Cosmetic and skin external preparation |
JP2017052706A (en) * | 2015-09-07 | 2017-03-16 | 一丸ファルコス株式会社 | Cosmetic composition containing granules |
TR201619953A2 (en) * | 2016-12-28 | 2018-07-23 | Buelent Karaagac | TOPICAL THERAPEUTIC FORMULATIONS |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022205059A1 (en) * | 2021-03-31 | 2022-10-06 | L'oreal | Compositions for caring for skin and a package for containing the same |
WO2022226872A1 (en) * | 2021-04-29 | 2022-11-03 | L'oreal | Kit for caring for the skin |
FR3122330A1 (en) * | 2021-04-29 | 2022-11-04 | L'oreal | SKIN CARE KIT |
FR3126303A1 (en) * | 2021-08-25 | 2023-03-03 | L'oreal | Mask for the care of keratinous materials |
WO2023184315A1 (en) * | 2022-03-31 | 2023-10-05 | L'oreal | Kit for caring for keratin materials |
WO2023184295A1 (en) * | 2022-03-31 | 2023-10-05 | L'oreal | Composition for caring for keratin material |
Also Published As
Publication number | Publication date |
---|---|
CN115192473A (en) | 2022-10-18 |
CN113194908B (en) | 2024-01-16 |
CN115192473B (en) | 2024-06-11 |
CN113194908A (en) | 2021-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2019047954A1 (en) | Kit for caring for the skin | |
WO2020001069A1 (en) | Kit for caring for the skin | |
CN113194908B (en) | Kit for caring skin | |
CN113226248B (en) | Kit for caring skin | |
US11304881B2 (en) | Composition based on an aqueous phase containing a dispersion of an anhydrous composite material | |
CN105163807B (en) | Gel-type cosmetic composite | |
CN113194906B (en) | Kit for skin care | |
WO2020181405A1 (en) | Kit for caring for the skin | |
WO2020133308A1 (en) | Kit for caring for the skin | |
WO2020258219A1 (en) | Kit for caring for the skin | |
WO2019185915A1 (en) | Foaming aqueous gel comprising a modified starch and a non-starchy polysaccharide | |
Gruber | Polysaccharide-based polymers | |
EP2945599B1 (en) | Cosmetic composition comprising a specific polysaccharide, an anionic fixing polymer and a liquid monoalcohol or polyol, and cosmetic treatment method employing it | |
WO2021217560A1 (en) | Kit for caring for the skin | |
WO2021245081A1 (en) | Composition comprising at least three types of polysaccharides, at least one pasty compound of plant origin and water | |
JP2024085649A (en) | Compositions Comprising a Combination of Electrolytes and Polysaccharides - Patent application | |
WO2022123016A1 (en) | Cosmetic substrate of natural origin | |
CN118973554A (en) | Composition for caring for keratin materials | |
WO2025059871A1 (en) | Compositions for skin care | |
WO2019185913A1 (en) | Anhydrous exfoliating composition comprising c3-c10 polyols and polysaccharides | |
WO2024128168A1 (en) | Composition comprising electrolyte and combination of polysaccharides | |
FR3023476A1 (en) | AQUEOUS SOLID COMPOSITION CONTAINING A FATTY ACID SALT, A POLYOL AND A HYDROPHILIC GELIFIER | |
Rinaudo | BETWEEN THE MOLECULAR STRUCTURE, THE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18945053 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18945053 Country of ref document: EP Kind code of ref document: A1 |